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Résumé 
La transcription, la maturation d’ARN, et le remodelage de la 
chromatine sont tous des processus centraux dans l'interprétation de 
l'information contenue dans l’ADN. Bien que beaucoup de complexes de 
protéines formant la machinerie cellulaire de transcription aient été étudiés, 
plusieurs restent encore à identifier et caractériser. 
En utilisant une approche protéomique, notre laboratoire a purifié 
plusieurs composantes de la machinerie de transcription de l’ARNPII humaine 
par double chromatographie d’affinité "TAP". Cette procédure permet 
l'isolement de complexes protéiques comme ils existent vraisemblablement in 
vivo dans les cellules mammifères, et l'identification de partenaires 
d'interactions par spectrométrie de masse. Les interactions protéiques qui sont 
validées bioinformatiquement, sont choisies et utilisées pour cartographier un 
réseau connectant plusieurs composantes de la machinerie transcriptionnelle. 
En appliquant cette procédure, notre laboratoire a identifié, pour la première 
fois, un groupe de protéines, qui interagit physiquement et fonctionnellement 
avec l’ARNPII humaine. Les propriétés de ces protéines suggèrent un rôle dans 
l'assemblage de complexes à plusieurs sous-unités, comme les protéines 
d'échafaudage et chaperonnes. 
L'objectif de mon projet était de continuer la caractérisation du réseau 
de complexes protéiques impliquant les facteurs de transcription. Huit 
nouveaux partenaires de l’ARNPII (PIH1D1, GPN3, WDR92, PFDN2, 
KIAA0406, PDRG1, CCT4 et CCT5) ont été purifiés par la méthode TAP, et la 
spectrométrie de masse a permis d’identifier de nouvelles interactions.  
Au cours des années, l’analyse par notre laboratoire des mécanismes de 
la transcription a contribué à apporter de nouvelles connaissances et à mieux 
comprendre son fonctionnement. Cette connaissance est essentielle au 
développement de médicaments qui cibleront les mécanismes de la 
transcription. 
Mots clés : Machinerie transcriptionnelle, ARN polymérase II humaine, 
purification TAP, partenaires d'interactions, réseau d’interactions. 
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Abstract 
Genomes encode most of the functions necessary for cell growth and 
differentiation. Gene transcription, RNA processing, and chromatin remodeling 
are central processes in the interpretation of the information contained in 
genomic DNA. Although many protein complexes forming the cellular 
machinery that interprets mammalian genomes have been studied, a number of 
additional complexes remain to be identified and characterized. 
Using proteomic approaches, Dr. Benoit Coulombe’s laboratory purified 
many components of the RNAPII transcription machinery using tandem affinity 
purification (TAP), a procedure that allows the isolation of protein complexes 
as they likely exist in live mammalian cells, and the identification of interaction 
partners using mass spectrometry. High confidence interactions were selected 
computationally and used to draw the map of a network connecting many 
components of the mRNA transcriptional machinery. By applying this 
procedure, our lab has identified, for the first time, a group of proteins, that 
interacts both physically and functionally with human RNAPII, and whose 
properties suggest a role in the assembly of multi-subunit complexes, acting as 
RNAPII-specific scaffolding proteins and chaperones.   
The aim of my project was to continue the characterization of the 
network of protein complexes involving transcription factors, and thus, further 
pursuing our survey of protein complexes in whole cell extracts. Eight novel 
RNAPII interaction partners (PIH1D1, GPN3, WDR92, PFDN2, KIAA0406, 
PDRG1, CCT4 and CCT5) were purified using the tandem affinity purification 
(TAP) method, and their interaction partners were identified by mass 
spectrometry. 
Over the years, our lab’s analysis of transcriptional regulation and 
mechanisms has contributed novel and important knowledge that provided 
better understanding of mRNA synthesis. This knowledge is paramount to the 
development of therapeutics that will target transcriptional mechanisms. 
Key words: Transcription machinery, human RNA polymerase II, TAP 
purification, interaction partners, interaction networks. 
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Section 1: Introduction 
 
1-1) From genes to proteins: 
Our genome, made of DNA (deoxyribonucleic acid), is the storehouse 
that contains all of the required information necessary to build an organism. It 
is arranged into 24 distinct chromosomes each of which contains many genes 
which encode proteins. Less than 2% of our genome encodes for genes, the 
equivalent of about 30000 genes, while the rest of our genome consists of non-
coding regions which are thought to play a role in maintaining the integrity of 
chromosomes and regulating the expression of proteins. 
 DNA consists of 4 different nucleobases, adenine, guanine, cytosine and 
thymine, and one DNA molecule can contain hundred million nucleotides. 
Nucleotides polymerize together, via phosphodiester bonds, to form nucleic 
acids, the linear representation of which constitutes the primary structure of 
nucleic acids. In fact, DNA is made up of two associated polynucleotide strands 
forming a double helix, where the two strands are complementary and oriented 
antiparallel to each other (Harvey Lodish et al., 4th edition).  
 This genetic material, DNA, carries the necessary information to specify 
the amino acid sequences of proteins each of which will have a specific 
function in the cell (Harvey Lodish et al., 4th edition). To interpret the 
information encoded by DNA, a transcription process occurs in which an 
enzyme, RNA polymerase, is recruited to the DNA and transcribes the 
information into RNA (ribonucleic acid). This RNA can then serve as template 
for the synthesis of proteins since each set of three ribonucleotides encodes an 
amino acid, the building block of proteins. This process occurs with the help of 
ribosomes which consist of ribosomal RNA (rRNA) associated to a set of 
proteins (Harvey Lodish et al., 4th edition). All of these processes will be 
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explained in greater details next, starting with the transcription of DNA to 
RNA. 
1-1.1) Transcription process:  
 Transcription is the process by which DNA is translated into RNA with 
the help of RNA polymerase enzymes. In eukaryotes, there exist three kinds of 
RNA polymerases (RNAP), RNAPI, RNAPII and RNAPIII; this is why genes 
are classified into three classes depending on the RNA polymerase enzyme that 
transcribes them. RNAPI, localized within the nucleoli, is the enzyme 
responsible for the transcription of ribosomal RNAs (rRNAs). On the other 
hand, RNAPII, which is localized within the nucleoplasm, transcribes all 
protein-encoding genes and certain small nuclear RNAs (snRNAs) genes. 
Finally, RNAPIII, which is also localized within the nucleoplasm, is the 
enzyme responsible for the transcription of transfer RNAs (tRNAs) and 5S 
rRNA (reviewed by Archambault et al., 1993).  
RNAPII transcription is the first step in gene expression and a focal 
point of cell regulation. It is a target of many signal transduction pathways, and 
a molecular switch for cell differentiation in development (Cramer et al., 2001). 
1-1.1.1) RNA polymerase II (RNAPII): 
 RNAPII is the enzyme responsible for the transcription of mRNA in 
eukaryotes. It is composed of 12 subunits, often referred to as Rpb1 to Rpb12 
by decreasing order of their molecular mass. Five of these subunits are common 
to all three RNA polymerases and they are Rpb5, 6, 8, 10 and 12, and only 
Rpb4, 7, 9 and the CTD of Rpb1 (see below) are unique to RNAPII.  Rpb1 and 
Rpb2 consist the two largest subunits and are responsible for most of the 
catalytic activity of polymerase (reviewed by et al.,, 2006).  
  Rpb1 also contains the CTD which consists of a tandem repeat of a 
heptapeptide: Tyr-Ser-Pro-Thr-Ser-Pro-Ser which appears 52 times in humans. 
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The CTD is an essential feature of RNAPII and is involved in transcription and 
mRNA processing. The CTD is disordered in RNAPII structures and tends to 
be degraded by proteases (reviewed by Thomas and Chiang, 2006). Depending 
on its phosphorylation state, RNAPII can exist in two forms; either the 
RNAPIIA, with an unphosphorylated CTD, involved in pre- initiation complex 
(PIC) assembly and transcription initiation, or RNAPIIO form, with a 
phosphorylated CTD, and is implicated in transcript elongation and termination 
(reviewed by Thomas et al., 2006). 
 Rpb4 and Rpb7 are two subunits of the RNAPII known to form a 
heterodimer required for the formation of the pre- initiation complex (PIC), the 
initiation of transcription, and RNA chain elongation (reviewed by Thomas et 
al., 2006). 
 Finally Rpb9, unique to RNAPII, plays an important role in 
transcription elongation, transcription-coupled DNA repair, and helps in the 
selection of the correct transcription start site and in maintenance of 
transcription fidelity (Chen et al., 2007). 
1-1.1.2) Recruitment of RNAPII to the promoter: 
On its own, RNAPII is unable to initiate transcription but rather requires 
other proteins, such as the general transcription factors (GTFs), involved in the 
recognition of promoter sequences, the response to regulatory factors, and 
conformational changes essential to the activity of the polymerase during the 
transcription cycle (reviewed by Hahn, 2004). The general transcription factors 
TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH assemble the RNAPII onto 
promoter DNA to form the Pre-Initiation complex (PIC). Refer to table 1 for a 
summary about the general transcription factors, their composition and function 
(adapted from a review by Thomas et al., 2006).   
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GTF Protein composition Function 
TFIIA 
P35 (α), P19 (β), P12 
(γ) 
-Stabilizes TBP- TATA complex  
-Anti repressor and a coactivator 
TFIIB P33 
--Start site selection; stabilizes TBP-
TATA complex, pol II/TFIIF recruitment 
TFIID 
TBP, TAFs (TAF1-
TAF14) 
-Core promoter- binding factor 
-Coactivator and a protein kinase 
-Ubiquitin- activating/ conjugating activity 
and Histone acetyltransferases 
TFIIE P56 (α), p34 (β) 
-Recruits TFIIH and is involved in 
promoter clearance 
-Facilitates formation of an initiation- 
competent RNAPII 
TFIIF RAP30, RAP74 
-Binds RNAPII and facilitates its 
recruitment to the promoter 
-Recruits TFIIE and TFIIH 
-Functions with TFIIB and RNAPII in 
start site selection 
-Promoter wrapping against RNAPII 
-Facilitates RNAPII promoter escape 
-Enhances the efficiency of RNAPII 
elongation 
TFIIH 
P89/XPB, p80/XPD, 
p62, p52, p44, 
p40/CDK7, 
p38/CyclinH, p34, 
p32/MAT1, p8/TFB5 
-ATPase activity for transcription 
initiation and promoter clearance 
-Helicase activity for promoter opening 
-Transcription- coupled nucleotide 
excision repair 
-Kinase activity for phosphorylating pol II 
CTD 
-E3 ubiquitin ligase activity 
Table I: Summary of the general transcription factors  
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Other proteins also regulate transcription, such as the mediator which is 
a large multiprotein complex that communicates directly with many gene-
specific regulators (Blackwell et. al., 2006), and sequence-specific DNA-
binding transcription regulators (i.e., activators and repressors) (Martinez, 
2002). 
 Transcription initiation proceeds through a number of specific steps. 
First, the packed chromatin must be de-condensed so that the transcriptional 
machinery could have access to the promoter region of a gene. Second, the 
binding of transcriptional activators to enhancer elements located close to or 
many thousands of base pairs away from the transcription start site. Finally, co-
activators are recruited to bring the RNAPII PIC to the site where the 
transcription activators are bound to enhancers (reviewed by Gross et al, 2006). 
1-1.1.2.1) The de-condensation of chromatin: 
Inside the non-dividing eukaryotic nuclei, huge DNA molecule is 
packaged, into filament with the help of proteins to form the 30 nm chromatin. 
This chromatin structure plays an important role in gene regulation since it 
presents an obstacle that must be overcome by transcription machineries to 
access the underlying DNA (reviewed by Ruthenberg et al., 2007).   
The first step in the transcription process is the binding of activators to 
enhancers which will recruit histone- modifying enzymes helping in the 
displacement of nucleosomes, as well as target the basal transcription 
machinery to the core promoter (discussed later on). The mediator, a co-
activator, is also involved and will serve as a bridge between the enhancer-
bound activators and the pre- initiation complex at the core promoter (reviewed 
by Szutorisz et al., 2005). The mediator is a multi- subunit complex, discovered 
by Roger D. Kornberg and R. Young at the same time, which is essential for 
transcription of class II genes. Figure 1 summarizes these processes (adapted 
from a review by Szutorisz et al., 2005). 
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Figure 1: Schematic representation of a proposed model for the activation 
of class II gene transcription. In the first step, the activator binds to the 
enhancer element and then recruits chromatin remodeling complexes to 
decondense the chromatin structure in step two. This is followed by the 
recruitment of the transcription machinery to the core promoter in step 
three. Finally in step 4, the enhancer- bound activator is brought into 
closer proximity, with the help of the mediator complex, to the 
transcription machinery at the core promoter.  
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1-1.1.2.1.1) Histones: 
Histones are the main protein components of chromatin and play a 
major role in the structure of chromatin. There are five major types of histones, 
called H1, H2A, H2B, H3 and H4, and these histones are present in almost all 
cell types. Four of these five types of histones, H2A, H2B, H3 and H4, 
specifically bind to DNA and they are the called “core” histones (reviewed by 
Lusser et al., 2003). Two of each assemble to form an octameric structure 
around which 146 base pairs of DNA are wrapped to form a structure called the 
nucleosome core, which is separated from other nucleosome cores by a thread 
of DNA referred to as the linker DNA. Together, one nucleosome core with a 
linker DNA, they form a complete chromatin subunit. H1, on the other hand, 
interacts with the nucleosomal core and the adjoining linker DNA (reviewed by 
Lusser et al., 2003). Histones protect the DNA, wrapped around them, from 
cleavage by endonucleases, whereas the linker DNA region is susceptible to 
endonucleolytic cleavages.  
Chromatin condensation creates an important obstacle for transcription, 
therefore, chromatin remodeling complexes and histone-modifying enzymes 
have to be recruited, by gene-specific regulatory factors, to de-condense the 
region where transcription is to be potentiated. 
 
1-1.1.2.1.2) Chromatin remodeling 
 1-1.1.2.1.2.1) Chromatin remodeling complexes: 
One class of chromatin remodeling complexes is the ATP-dependent 
molecular machine, which uses the hydrolysis of ATP to modulate the 
interactions between DNA and histones in the chromatin. Although they are 
very different in composition and in function, these complexes share an ATPase 
subunit which belongs to the Snf2-like family (reviewed by Lusser et al., 2003). 
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ATP-dependent chromatin remodeling complexes are divided into three groups 
depending on their biochemical properties and the sequence similarity of their 
ATPase subunits. 
The first group is the SWI/SNF group, which plays a role in the 
activation of transcription. Then there are the ISWI and the Mi-2/CHD groups, 
both of which are involved in the repression of transcription (reviewed by 
Peterson, 2002).  
The most studied of these groups is the SWI/SNF group, which can 
modulate chromatin structure by helping DNA-bending proteins facilitate 
nucleosomal sliding, as well as disrupting high-order chromatin folding and 
nucleosomes (reviewed by Peterson, 2002, and by Vignali et al., 2000). 
1-1.1.2.1.2.2) Histone modifications: 
 Histones can also undergo posttranslational modifications that can alter 
their interaction with DNA. Different histone modifications can have a role in 
different biological processes such as, gene regulation, DNA repair or DNA 
chromatin condensation. Some of these modifications include the acetylation of 
lysines, the methylation of lysines and arginines, the phosphorylation of serines 
and threonines, the ubiquitination of lysines, the sumoylation of lysines, and the 
ADP-ribosylation of glutamic acids (reviewed by Khorasanizadeh, 2004). The 
enzymes responsible for these modifications are the histone acetyltransferases 
(HAT), histone deacetylases (HDAC), histone methyltransferases, kinases for 
phosphorylation, ubiquitinases and poly-(ADP-ribose) polymerases (reviewed 
by Davie, 1996). Most modifications localize to the amino- and carboxy-
terminal histone tails, and a few localize to the histone globular domains 
(reviewed by Berger, 2007). As to the modifications that are involved in the 
regulation of transcription, they are divided into two groups, either activating or 
repressing transcription. These modifications are summarized in table 2 
(adapted from a review by Berger, 2007).  
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Histone 
post-translational 
modification 
Transcriptionally 
relevant sites 
 
Transcriptional role 
Acetylated Lysine 
H3 (9,14,18,58), H4 
(5,8,13,16), H2A, H2B 
Activation 
Phosphorylated Serine/ 
Threonine 
H3 (3,10,28), H2A, 
H2B 
Activation 
Methylated Argenine H3 (17,23), H4 (3) Activation 
Methylated Lysine 
H3 (4,36,79) 
H3 (9, 27), H4 (20) 
Activation 
Repression 
Ubiquitylated Lysine 
H2B (123 in yeast,120 
in mammals) 
H2A (119 in mammals) 
Activation 
 
Repression 
Sumoylated Lysine H2B(6/7), H2A (126) Repression 
 
Table II: Histone post- translational modifications affecting transcription 
 
1-1.1.2.2) Assembly of the RNAP II Pre- Initiation Complex (PIC): 
Once the chromatin has de-condensed to a more accessible structure, the 
gene- specific regulatory factors, already bound to the site of transcription 
initiation, will now recruit the RNA polymerase II to the core promoter where 
the pre-initiation complex can assemble.  
1-1.1.2.2.1) Core promoter: 
A core promoter (Figure 2) is defined as the minimal portion of DNA 
sequence, located upstream of a gene, required to properly initiate transcription.  
It most commonly consists of elements such as the TATA box, which is present 
25- 30 bps upstream of the transcription start site (+1), and is an AT rich 
sequence that is recognized by the TBP protein (TATA-binding protein),  
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Figure 2: The core promoter 
Schematic representation of the core promoter needed for basal 
transcription by the RNAPII enzyme. What is shown are the elements that 
most commonly consist the core promoter (TATA box, BREu and BREd, 
Inr, DPE, MTE and finally DCE). 
 
 
a subunit of the TFIID general transcription factor. The initiator element (Inr), 
which has a conserved sequence, is located at the +1 site. The Inr is 
functionally similar to the TATA box (-25 to -30 bps away from the Inr 
position at +1), and can function independently of the TATA box when they are 
more than 30 bps apart, otherwise, these two elements function synergistically 
(reviewed by Smale et al., 2003). The Inr element is also recognized by TFIID, 
through its TAF (TBP associated protein) subunits, TAF1 and TAF2 (reviewed 
by Smale, 1997, and by Thomas and Chiang, 2006). Another element is the 
DPE (downstream promoter element), present at +28 - +32 relative to the +1 
position. This element is conserved from Drosophila to humans and is required 
for the binding of purified TFIID (through its TAF6 and TAF9 subunits) to a 
subset of TATA-less promoters. The DPE element also acts in conjunction with 
the Inr element (reviewed by Smale et al., 2003, and by Thomas and Chiang, 
2006).  
In addition to DPE, two other core promoter elements are present 
downstream of the transcription start site, and they are the MTE and DCE 
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elements. The MTE (Motif Ten Element) is positioned between +18 to +29, and 
normally functions in conjunction with Inr to enhance transcription by RNAPII. 
It can also work synergistically, in an Inr-dependent manner, with the TATA 
box and DPE, or without them (when they are not present), to strengthen the 
promoter activity. DCE (Downstream Core Element), on the other hand, is 
found between +6 to +34 and is recognized by the TAF1 subunit of TFIID 
(reviewed by Thomas et al., 2007, and by Thomas and Chiang, 2006). The 
DCE contributes to the transcriptional activity and binding of TFIID (reviewed 
by Smale et al., 2003).  
The core promoter also consists of a BRE (TFIIB recognition element) 
which could be present at two positions, upstream of the TATA box (BREu) 
and downstream (BREd) of the TATA box. BREd, bound to TFIIB, was shown 
to modulate promoter strength and act as a positive element for transcription 
when the promoter contains only the BREd element. However, in the presence 
of BREu, BREd has a negative effect on transcription. BREu, on the other hand, 
might have a positive or negative effect on transcription of TATA-less 
promoters likely to contain BREu, rather than the TATA-containing promoters 
(Deng et al., 2006).   
Although most core promoter studies were conducted on TATA box 
containing promoters, it turns out that the majority of mammalian genes have 
TATA-less promoters within which are present multiple start sites, generating 
diversity and complexity. This indicates that TATA-driven PIC assembly is the 
exception, rather than the rule, in eukaryotic transcription (reviewed by 
Sandelin et al., 2007).  
1-1.1.2.2.2) Recruitment of RNAPII to the core promoter: 
This process starts with the formation of the PIC, which consists of the 
RNAPII and several general transcription factors including TFIIA, TFIIB, 
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TFIID, TFIIE, TFIIF and TFIIH. The assembly of the PIC is thought to proceed 
in two different pathways.  
The first pathway is called the “sequential assembly pathway” where the 
TBP protein of TFIID first binds to the promoter region at the TATA box, 
resulting in the bending of the DNA at an 80° angle (Kim J. L. et al., 1993, Kim 
Y. et al., 1993). This event is followed by the entry of TFIIA and TFIIB, both 
of which will help in stabilizing the TFIID bound to promoter. TFIIB will help 
in facilitating the recruitment of the RNAPII- TFIIF complex (reviewed by 
Thomas et al., 2007). The entry of TFIIF induces a second bending of the 
DNA, close to the +1 site, causing the wrapping of the promoter region around 
the RNAPII (Robert et al., 1998, reviewed by Coulombe and Burton, 1999). 
This event is finally followed by the entry of TFIIE and TFIIH. 
The second pathway is known as the “RNAPII holoenzyme pathway”, 
where the RNAPII is present in a pre-assembled holoenzyme complex 
containing the RNAPII and suppressors of RNAPII mutations, with or without 
a subset of general transcription factors. In addition, other proteins associated 
with chromatin remodeling, DNA repair, and mRNA processing, are involved. 
This holoenzyme complex would be recruited to a transcription site by TFIID 
bound to a promoter (reviewed by Thomas et al., 2007). Evidences supporting 
both models have been reported. Thus, it is likely that both assembly pathways 
exist in vivo. 
In both pathways, it is clear that each general transcription factor 
involved plays an essential role in transcription. For example, when the TBP 
subunit of TFIID binds to the TATA box of the promoter, it bends the DNA 
around the RNAPII bringing it closer to the transcription start site. Furthermore, 
when TFIIH is recruited, it introduces negative superhelical tension in the 
DNA, through its ATPase/Helicase subunit, producing a transient bubble. 
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Finally initiation and RNA synthesis can be potentiated with the addition of two 
nucleoside triphosphates (NTPs) (reviewed by Kornberg, 2007). 
 
1-1.1.3) Initiation: 
The initiation process does not start smoothly; up until positions +8/+10 
multiple rounds of abortive initiation occur resulting in the production of short 
(2- 9 nucleotides) transcripts. These rounds proceed until the complex reaches a 
point where it is stabilized, usually at position +9, and this transition is referred 
to as “promoter escape”. Soon after promoter escape, RNAPII pauses again and 
this phenomenon is called the “promoter-proximal pausing”, in which a large 
number of genes have been shown to be regulated (reviewed by Margaritis et 
al., 2008). 
1-1.1.3.1) mRNA processing prior to productive elongation: 
The transcription of mRNA is tightly coupled to the recruitment of the 
mRNA processing machinery. The initial transcripts synthesized by the 
RNAPII, called pre-mRNAs, have to be processed to form the mRNA before 
getting exported to the cytoplasm. The first processing step in all eukaryotic 
cells occurs as soon as the transcript is ~25 bases long. An m7G cap is added to 
the 5'-end of the transcript by a capping enzyme bound to the phosphorylated 
CTD. This cap modification has been shown to occur during the arrest of the 
transcription process, prior to its entry in the productive elongation phase. This 
suggests that the capping enzyme might play an important role as a checkpoint, 
ensuring that uncapped transcripts are not elongated. Once the 5'-end is capped, 
introns are excised with the help of the spliceosome, one of the largest 
macromolecular machines in the cell, also brought to the transcription site 
through interaction with the CTD of RNAPII (reviewed by Almeida et al., 
2008). 
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1-1.1.4) Elongation: 
Once the RNAPII has escaped the promoter it enters the elongation 
phase. At this stage all of the general transcription factors dissociate to form the 
“transcription elongation complex”, except for TFIIF. This phenomenon is 
referred to as the “Promoter clearance step”. 
 Promoter clearance has been shown to coincide with phosphorylation 
of the CTD of RNAPII, which plays an important role in recruiting protein 
factors involved in elongation, as well as in mRNA maturation, surveillance, 
and export.  Other elongation factors are recruited at this stage to the RNAPII 
to modulate its catalytic activity and form the transcription elongation complex. 
This includes factors such as Elongins, P-TEFb, DSIF and NELF, which can all 
influence the pausing of the RNAPII, either positively or negatively. FACT, a 
histone chaperone, is another elongation factor recruited to help facilitate the 
elongation process by remodeling the chromatin (reviewed by Sims et al., 
2004). 
 
1-1.1.5) Termination and 3'-end mRNA processing: 
Termination is the last step of transcription by the RNAPII and it is a 
process that depends on pre-mRNA 3'-end processing signals, such as the 
poly(A) signal. Therefore, once the poly(A) signal has been read by the 
RNAPII, it is recognized by a multi-component cleavage/polyadenylation 
complex recruited to the RNAPII through the CTD of Rpb1. This complex will 
direct the endonucleolytic cleavage and the polyadenylation of the free 3'-end 
(reviewed by Lykke-Andersen et al., 2007, and Kim et al., 2003). Poly(A)-
binding proteins are then recruited to the 3’end of the processed transcript to 
help protect it from exonucleolytic degradation. Other signals also exist on 
different transcripts, such as the snRNAs and the snoRNAs, and are recognized 
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by other protein complexes, also recruited to RNAPII through the CTD of 
Rpb1, which contain the RNA binding proteins Nrd1p, Nab3p, and additional 
co-factors (reviewed by Lykke-Andersen et al., 2007, and Kim et al., 2003).  
 
1-1.2) mRNA export: 
 The transcription process is also coupled to the nuclear export of 
mRNAs, which is an essential process for the expression of genes in all 
eukaryotic cells. Therefore, as soon as the mRNA is synthesized, proteins are 
recruited forming the mRNA ribonucleoprotein particles (mRNPs). Export 
machineries will recognize signals within the proteins of mRNPs rather than 
within the mRNA itself, and will export the mRNA to the cytoplasm where the 
proteins synthesis occurs (reviewed by Iglesias et al., 2008). 
 
1-1.3) Protein synthesis:   
Translation is the process by which mRNAs are used to direct the 
synthesis of polypeptide chains in three different steps, including initiation, 
elongation, and termination. This process is catalyzed by a complex called the 
ribosome which is, in fact, a ribozyme with RNA at the heart of its enzymatic 
activity (reviewed by Steitz, 2008 and by Culver, 2001). Mammalian ribosomes 
are only found in the cytosol and in the mitochondria (reviewed by Hebert et 
al., 2007). 
 The eukaryotic ribosome is a complex that consists of two asymmetric 
ribonucleoprotein subunits, the 60s and the 40s subunits, which will bind the 
mRNA and use it as a template to catalyze the correct assembly of amino acids 
into polypeptide chains. tRNAs are the adaptor molecules used by ribosomes to 
decode the information in the mRNA. They are present at the interface between 
the mRNA and the growing amino acid chain. 
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There exits three tRNA-binding sites in a ribosome, the A, P and E sites. 
The A site is the site of entry of a cognate aminoacyl tRNA. The P site is the 
site of the peptidyl tRNA, where the elongation of the polypeptide chain occurs. 
The amino acid bound to the tRNA in the A site is transferred to the growing 
polypeptide chain bound to the tRNA in the P site. The E site is the exit site, 
occupied by the deacylated tRNA. An exception occurs during the initiation 
step where the cognate aminoacyl tRNA carrying a methionine enters the P site 
rather than the A site and base pairs with the start codon of the mRNA 
(reviewed by Culver, 2001). The translation ends once a stop codon is read by 
the tRNA; at this point the polypeptide chain separates form the tRNA, which 
itself separates from the ribosome. Finally the ribosomal subunits separate from 
the mRNA. 
 
1-1.4) Protein folding: 
 Following the synthesis of a new polypeptide chain, its correct folding 
will convert it into the mature, active protein which can then be localized to its 
appropriate location (reviewed by Hebert et al., 2007). This process will 
normally take place either in the cytoplasm, for cytoplasmic proteins, or in the 
endoplasmic reticulum, for transmembrane and secretory proteins (reviewed by 
Paulsson et al., 2003). The information needed for the correct folding of a 
protein is encoded by its amino acid sequence. The protein folding process 
requires most of the time the assistance of a network of molecular chaperones 
to support the folding in vivo. This is important to prevent aggregation in the 
crowded intracellular environment, and prevent inappropriate inter- and intra-
molecular interactions (reviewed by Deuerling et al., 2004). As soon as the 
nascent polypeptide emerges from the ribosome, the ribosome-associated 
chaperones guide its folding. Finally, once a protein has been properly folded 
by a chaperone, it must be localized to its appropriate subcellular compartment. 
17 
 
Chaperones will help these proteins find their way to the place where they can 
display their appropriate function (Lund et al., 2003). 
 
1-1.4.1) Molecular Chaperones: 
Molecular chaperones exist in all organisms and in all cellular 
compartments. They are defined as a large group of proteins that share the 
property of assisting the folding, unfolding, assembly and disassembly of other 
macromolecular structures (reviewed by Ellis, 2006). Furthermore, chaperones 
have also been shown to play a role in the translocation of newly synthesized 
proteins (reviewed by Nicoll et al., 2005). The main chaperone classes are the 
Hsp40 (the DnaJ family), Hsp60 (includes GroEL and T-complex polypeptide 1 
(TCP-1) ring complexes), Hsp70, Hsp90 (reviewed by Fink, 1999) and the 
AAA+ superfamily of ATPases. 
1-1.4.1.1) Hsp40 family: 
 The best defined role for Hsp40 is as a cochaperone for the Hsp70.  This 
family of proteins consists of over 100 members, defined by the presence of 
three distinct domains. The first is a highly conserved J- domain of ~70 amino 
acids near its N-terminus, responsible for the interaction with Hsp70. The 
presence of a J- domain in a protein defines it as a DnaJ-like protein, and is 
involved in regulating the ATPase activity of the Hsp70 (Hennessy et al., 
2000). The second domain is a glycine and phenylalanine rich region that acts 
as a flexible linker. Finally, the third domain is a cysteine-rich, zinc finger-
containing C-terminus domain (Cheng et al., 2008, and reviewed by Fink 
1999).   
1-1.4.1.2) Hsp70 family: 
 Members of this family help to protect cells from stress, aside from 
playing an important part in protein folding. They are characterized by a very 
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weak ATPase activity which is stimulated by the binding of the Hsp40 
cochaperone. They are composed of two major functional domains; an N-
terminal ATPase domain and a C-terminal domain that is responsible for the 
binding of polypeptides. Some of the better known mammalian members of this 
family include the constitutive cytosolic member HSC70, the stress- induced 
cytosolic form HSP70, the ER form BiP and the mitochondrial form mHSP70 
(Morano KA, 2007, and reviewed by Fink 1999).  
1-1.4.1.3) Hsp90 family: 
 Hsp90 is one of the most abundant chaperones in the cell found to be 
upregulated in response to stress. It also pays an important role, under normal 
conditions, in protein folding, intracellular transport, and stability of proteins 
many of which are critical for signal transduction. Mammalian Hsp90 exist as 
dimers and is often found in complexes with other chaperones. Members of this 
family of proteins are highly conserved in all organisms from bacteria to 
humans and are essential. Examples of the Hsp90 family include the cytosolic 
form, HSP90A, the endoplasmic reticulum form, HSP90B and the 
mitochondrial form, TRAP (reviewed by Fink, 1999, and by Pearl et al., 2008). 
 Hsp90 has an ATPase activity and contains three functional domains. 
The first is the ATP binding domain near the N- terminus. The other two 
domains are the protein binding and the dimerization domains located near the 
C-terminus of the Hsp90 protein. All of these domains play an important role in 
the function of the protein (Southworth et al., 2008, Barginear et al., 2008 
reviewed by Fink, 1999).    
1-1.4.1.4) Hsp60 family/ Chaperonin family: 
 This family of proteins is the best studied of the chaperones, and is 
divided into two families/ groups; the GroEL (also called group I) and the TCP-
1 ring complex families (also called group II), both of which are represented 
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schematically in Figure 3 (Figure 3 is adapted from Martin- Benito et al., 2007, 
Martin- Benito et al., 2002, and Roseman et al,. 1996). Members of this family 
are involved in the assembly of large multiprotein complexes (reviewed by 
Fink, 1999). Hsp60 genes are highly conserved, indicating a central role in cell 
viability (Lund et al., 2003). 
1-1.4.1.4.1) GroEL family: 
 This family of proteins is found in prokaryotes, chloroplasts, and 
mitochondria. The vast majority of organisms contain at least one gene for this 
protein. GroEL requires the assistance of a cochaperone called GroES “lid” and 
the presence of ATP to facilitate the folding of newly synthesized polypeptides. 
Substrates of this group of chaperones include several metabolic enzymes, 
RNA polymerase II subunits, and other proteins involved in transcription and 
translation (reviewed by Fink, 1999). GroEL chaperones have also been shown 
to play a role in conformational maintenance of pre-existing proteins, secretion, 
and proteolysis (Houry et al., 1999, Kusukawa et al., 1989, Kandror et al., 
1994, and reviewed by Deuerling et al., 2004). GroEL is composed of two 
heptameric rings, of the large subunit GroEL, stacking back to back and 
forming a 14-subunit hollow cylinder (Lund, 2001). Binding of ATP and 
GroES induces large conformational changes in GroEL providing a polar 
environment favorizing the folding of the encapsulated protein. Then ATP 
hydrolysis primes the GroEL to release GroES “lid”, allowing the folded 
substrate to exit the chaperone (Lund et al., 2003, reviewed by Fink, 1999 and 
reviewed by Deuerling et al., 2004).  
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Figure 3: The GroEL and the TCP-1 ring complex families  
A) Left: A side view of the GroEL chaperone in the ATP bound state. This 
view shows the two heptameric ring. Right: A side view of the GroEL 
chaperone in the ATP bound state in the presence of the GroES 
cochaperone.  
B) Left: A side view of the TCP-1 ring complex chaperone showing the 
two octameric rings. Right: A top view of the TCP-1 ring complex 
chaperone showing the protrusion “lid”. 
C) The prefoldin complex with its six subunits (red arrows point to the six 
subunits).   
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1-1.4.1.4.2) TCP-1 ring complex family:  
 The TCP-1 complex is an ATP-dependent complex found in the 
eukaryotic cytosol, and is composed of two identical stacked rings, each 
composed of eight different proteins referred to as CCT1 (also referred to as 
TCP-1) to CCT8 encoded by different genes. This family of proteins does not 
require the assistance of a cochaperone such as the GroES, but is rather 
characterized by the presence of a portrusion “lid” on the TCP-1 ring complex, 
which is actually part of the CCT protein itself. TCP-1 ring complexes are 
chaperones that assist in the folding of a small number of proteins, mainly actin 
and tubulin (Yam et al., 2008, Lund et al., 2003, reviewed by Fink, 1999, and 
Llorca et al., 1999).  
   1-1.4.1.4.2.1) The prefoldin complex: 
The TCP-1 ring complex does not function alone in the folding of actin 
and tubulin, but rather requires the assistance of another molecular chaperone 
named prefoldin. The prefoldin complex itself is a heterohexameric complex 
found in archaeabacterial and eukaryotic organisms (Martin- Benito et al., 
2002). In eukaryotes, the prefoldin complex is an oligomer composed of six 
different proteins (PFDN1- PFDN6). The archaeal prefoldin chaperone, on the 
other hand, is an oligomer composed of two different proteins, two α-subunits 
and four β-subunits (Martin- Benito et al., 2002).   
Actins and tubulins are very abundant and highly conserved proteins 
involved in processes which are essential and unique to eukaryotes. These 
processes include muscle contraction, segregation of chromosomes, 
stabilization and alteration of cell shape, endocytosis and exocytosis to mention 
a few (Leroux et al., 2000, Gu et al., 2008). Once the N-terminus (~145 amino 
acids) of the actin or tubulin nascent chains have been synthesized, the 
prefoldin complex binds to it and keeps the polypeptide chain in an unfolded 
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state until its synthesis is complete. After which, the polypeptide is delivered to 
the TCP-1 complex for proper folding (Hansen et al., 1999, Gu et al., 2008).  
1-1.4.1.4.3) The AAA+ superfamily of ATPases: 
AAA stands for ATPases Associated with diverse cellular Activities 
(Kunau et al., 1993). The AAA+ superfamily is a large and functionally diverse 
superfamily of NTPases that are characterized by a conserved nucleotide-
binding and catalytic module, the AAA+ module (Snider et al., 2008). 
Members of the AAA+ superfamily of ATPases are found in all three kingdoms 
of life and function in diverse cellular processes, often via chaperone-like 
activities (Zhang et al., 2002; Ogura and Wilkinson, 2001). AAA+ proteins 
typically assemble into hexameric ring complexes that are involved in the 
energy-dependent remodeling of macromolecules (Iyer et al., 2004, Snider et. 
al. 2008). The defining feature of AAA+ proteins is a structurally conserved 
ATP-binding module of 200-250 amino acids, that oligomerizes into active 
arrays (reviewed by Erzberger et al., 2006, Ogura and Wilkinson 2001). ATP 
hydrolysis by the AAA+ protein is coupled to physical contact with the target 
substrate molecule and requires that specific interaction for remodeling of the 
substrate to take place (Zhang et al., 2002).  
 
1-2) Protein complexes: 
Many cellular functions are performed by multiprotein complexes. For 
example, the RNA pol II enzyme which itself is composed of 12 subunits, that 
need to come together and interact with each other to form the enzyme. Once 
formed, this enzyme requires the assistance of the general transcription factors 
which will be recruited, and interact with it, to facilitate the transcription 
process. Another example of multiprotein complexes is the chaperones 
themselves. Chaperones are often composed of different proteins that interact 
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with each other to form the active chaperone; for example, the TCP-1 ring 
complex with its 8 subunits that need to interact with each other to generate the 
active chaperone activity. Furthermore, these chaperones will often require the 
assistance of cochaperones to facilitate the folding process of proteins. 
All of this point to the fact that, proteins do not function on their own 
but are usually grouped into larger complexes to perform a specific function in 
an organism (Gingras et al., 2005). Therefore, it is clear that the study of 
protein complexes is important, since it allows placing proteins of an unknown 
function into a functional context provided by their interactions with other 
proteins in the complex (reviewed by Bauer et al., 2003). Therefore, the 
network of interacting partners in which a certain protein is present and its 
position within the network provide important information in defining its 
function (Jaeger et al., 2008). This also applies to the analysis of proteins of 
known function which often play a role in different complexes and subcellular 
compartments. Thus, large-scale functional proteomics projects, which build 
interaction networks of protein complexes, can help in understanding the cross- 
talk that goes on between the different complexes of unconnected cellular 
activities (reviewed by Bauer et al., 2003). 
From a pharmacological point of view, numerous human diseases are 
caused by defects in cellular signal transduction pathways. These signaling 
pathways, themselves, are regulated by protein- protein interactions which often 
involve the assembly of large signaling complexes. Therefore, while studying 
protein complexes, if a protein is found to interact with proteins of a specific 
pathway, it can represent a new potential drug target of that pathway (reviewed 
by Shiota et al., 2008). 
In the past, drug discovery efforts focused on a relatively limited 
number of proteins against which compounds could be developed such as, G-
protein coupled receptors. The identification and validation of new drug targets 
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was a very difficult, time consuming and expensive process, discouraging 
investments in drug discovery programs (reviewed by Kramer et al., 2004, and 
by Ruffner et al., 2007). Nowadays, large-scale, genome-wide protein-protein 
interaction screens have a great potential in identifying novel therapeutic targets 
and are key in understanding the functions and molecular mechanisms of 
diseases (Ruffner et al., 2007).  
 
1-2.1) Methods for studying protein- protein interactions and protein 
complexes in eukaryotes: 
 
 Several different methods have been developed for studying protein-
protein interactions such as affinity chromatography technique, phage display, 
co-immunoprecipitation experiments, and the BRET and FRET methods. 
Recently new approaches, such as LUMIER and PCA, have also been 
developed, but the main two methods used currently are the yeast two- hybrid 
method and the tandem affinity-purification procedure coupled to mass 
spectrometry.  
1-2.1.1) The affinity chromatography technique: 
This is a technique that requires the fusion of the protein of interest to an 
affinity tag. Cells are transfected with the plasmid coding for the protein of 
interest fused to the affinity tag (Berggård et al., 2007). After an appropriate 
expression period, the cells are lysed and the tagged protein of interest is 
purified together with all its interaction partners using a specific ligand linked to 
a solid support (Berggård et al., 2007). Eluted proteins are then separated on 
gel-electrophoresis and the proteins are identified by mass spectrometry 
(Berggård et al., 2007). 
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Although this technique could be used for the identification of protein-
protein interactions, it is prone to generate higher backgrounds and thus, the 
small amounts of specific interaction partners may be masked by more abundant 
non- specific binding proteins (Berggård et al., 2007). Another disadvantage of 
affinity chromatography is the fact that the protein of interest must be fused to a 
tag. The tag may cause a problem if it gets buried inside the complex and thus, 
the purification of the complex may not be achieved (Berggård et al., 2007). An 
exogenous tag might also perturb the interaction of the fused protein of interest 
with other proteins in the complex (Berggård et al., 2007). 
1-2.1.2) Phage display: 
Phages are viruses that infect bacterial cells (Smith et al., 1997). In the 
phage display technique, the protein of interest are fused to a coat protein of a 
phage particle (Goodyear et al., 2008) so that the protein of interest is displayed 
on the outer surface of a phage particle once released from the transformed 
bacterial cell (Smith et al., 1997), thus making it accessible to other proteins for 
subsequent binding interactions (Goodyear et al., 2008). This characteristic 
enables the selection of specific binding interactions from a mixture of 
nonbinding particles (Goodyear et al., 2008). Selected phage particles are then 
eluted and used to infect fresh bacteria and the process is repeated until the 
desired enrichment is reached (Goodyear et al., 2008). Therefore, during the 
selection process, specific phage clones are progressively enriched on the basis 
of their specificity and affinity for a protein. 
Although Phage display can be used in to identification of new protein-
protein interactions, the technique itself suffers from several limitations such as, 
non-specific binding, elution efficiency, and differences in the ability of the 
eluted phages to re-infect and propagate in bacterial cells (Rhyner et al., 2004). 
Recently, display systems, such as the bacterial 2-hybrid display system, have 
been developed and have shown to produce less background, than the classical 
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phage display system, in studying protein-protein interactions (Bair et al., 
2008).  
1-2.1.3) Co-ImmunoPrecipitation (Co-IP) method: 
Co-IP is a technique that uses the specificity of antibodies to purify a 
target protein together with its interaction partners (Kaboord et al., 2008). To do 
so, whole cell extracts are prepared under nondenaturing conditions to maintain 
any interactions that occur. Cell extracts are then incubated with an antibody 
specific to the protein of interest “bait”, provided that the antibody-protein 
interaction does not interfere in the interaction of the bait with other proteins 
within the cell extract (Yaciuck, 2007, and Miernyk et al., 2008). The antibody-
bound protein complex is then isolated on protein A or protein G sepharose 
beads. Proteins that did not bind to the beads are removed by a series of washes, 
and the bound protein complex is eluted from the beads. Members of the 
complex are then dissociated from each other by SDS sample buffer and then 
run on an SDS-PAGE followed western blotting with antibodies specific to the 
bait or interaction partners (Yaciuck, 2007, and Miernyk et al., 2008). 
1-2.1.4) BRET and FRET methods: 
BRET (Bioluminescence Resonance Energy Transfer) is a method that 
takes the advantage of the resonance energy transfer between a luminescent 
donor (usually a luciferase) and a fluorescent acceptor (such as YFP). In this 
approach, the protein of interest must be fused to the bioluminescent donor 
and the suspected interacting partner must be fused to the fluorescent acceptor 
(note: the inverse is also plausible where the bait is fused to the fluorescent 
acceptor and the interacting partner is fused to the bioluminescent donor, 
since this methods only checks to see if an interaction occurs between two 
proteins). When the two proteins do not interact, only one signal, emitted by 
the luciferase, can be detected. It is only when the proteins are brought into 
close proximity of each other, typically at a distance of 100Å or less, that the 
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energy transfer occurs, and in this case an additional signal, emitted by the 
fluorescent protein, can be detected. This distance (100Å) is generally 
indicative of interaction between the two fused proteins of interest, either 
directly or as part of a complex (reviewed by Pfleger et al., 2006, Boute et al., 
2002). 
 FRET (Fluorescence Resonance Energy Transfer), on the other hand, is 
a method that also exploits the advantage of resonance energy transfer, but this 
time between a fluorescent donor (example CFP) and a fluorescent acceptor 
(example YFP), provided that the two fluorophores are different. FRET is 
observed when the sample is exited at the wavelength of excitation of the donor 
(Tramier et al., 2002, Evans et al., 2006, and Gandía et al., 2007). Now excited, 
the donor will emit energy at a wavelength that superimposes with the 
wavelength at which the acceptor is excited. This would only occur when the 
two proteins are in a close proximity of each other, 10-100Å in the case of 
FRET compared 100Å in the case of BRET, indicating an interaction between 
the two fused proteins of choice (Tramier et al., 2002, Evans et al., 2006, and 
Gandía et al., 2007).  
The advantages of the previous two approaches (BRET and FRET) are 
that they both measure protein-protein interactions (either direct or indirect 
interactions) in vivo, and do not require the lysis of cells or the purification of 
proteins. Their disadvantages, on the other hand, is that they require ectopic 
expression and/or overexpression of the fusion proteins which may cause 
artifacts that can either inhibit or induce protein- protein interactions (Bhat et 
al., 2006). Furthermore, expensive high- resolution microscopes are required to 
measure both BRET and FRET. 
1-2.1.5) LUMIER: 
LUMIER (LUminescence-based Mammalian IntERactome) is an 
automated high-throughput technology aimed at mapping protein-protein 
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interaction networks systematically in mammalian cells (Barrios-Rodiles et al., 
2005). This approach uses Renilla luciferase enzyme fused to proteins of 
interest, which are then coexpressed with individual Flag-tagged partners in 
mammalian cells. Cell extracts are then prepared and the interactions are then 
determined by performing an Renilla luciferase enzymatic assay on the 
immunoprecipitates using an antibody against Flag (Barrios-Rodiles et al., 
2005). 
An advantage of LUMIER is the fact that it can detect, in mammalian 
cells, interactions involving transmembrane receptors which play an important 
role in signaling networks (Barrios-Rodiles et al., 2005). Previously, studying 
transmembrane receptors has shown to be a difficult task using other high-
throughput approaches. However, the disadvantages are that the LUMIER 
technique is not able to measure absolute protein-protein interaction affinities, 
and is prone to generate false positives due to overexpression of the fused 
proteins (Barrios-Rodiles et al., 2005).   
1-2.1.6) The PCA approach: 
PCA (protein-fragment complementation assays) is a technique that 
measures protein- protein interactions by fusing each of the proteins of interest 
to two fragments of a reporter protein that has been dissected into two fragments 
using protein-engineering strategies (Michnick et al., 2007). If the interaction 
does indeed occur, the reporter-protein fragments are brought into proximity 
allowing them to fold together into the unique three-dimensional structure of the 
reporter protein and reconstitute its activity (Michnick et al., 2007).  
The advantage of PCA is that it can be created with many reporter 
proteins and thus provides for different types of readouts depending on the 
desired application (Michnick et al., 2007). Furthermore, proteins are expressed 
in the relevant cellular context, and thus subcellular localizations and 
translocations of protein complexes can be determined (Michnick et al., 2007). 
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On the other hand, PCA does require the fusion of the proteins of interest to 
unfolded fragments of the PCA reporter protein which could perturb the 
function of the proteins of interest. 
LUMIER and PCA are both approaches that have not been widely used 
nor reported until now, but they for sure promise to serve in enhancing the 
confidence of protein-protein interactions by helping to describe the local 
topology of protein interaction networks (Figeys et al., 2008). 
1-2.1.7) The yeast two-hybrid method:  
The yeast two- hybrid method is a sensitive, in vivo assay, which has 
proved, over the past several years, to be extremely effective in studying 
protein-protein interactions (Brachmann et al., 1997, Ito et al., 2001).  In fact, 
the first interactome maps were obtained using this method (reviewed by 
Gingras et al., 2007). 
The method consists of developing yeast strains that carry a reporter 
gene, the most common of which is LacZ, with a unique promoter structure. The 
most common system used for studying protein-protein interactions is the 
GAL4 system which relies on a transcriptional readout for the detection of 
protein- protein interactions through the reconstitution of a functional 
transcriptional activator (Luban et al., 1995, Brachmann et al., 1997, and 
reviewed by Causier, 2004). GAL4 is a transcriptional activator containing two 
separate domains, the DNA-binding domain and the transcription activation 
domain. In two- hybrid assays, these two domains are separated from each other 
and fused to two proteins which are suspected to interact. In the case where an 
interaction does occur between the proteins, then the two domains are brought 
close together, reconstituting the GAL4 transcriptional activator. GAL4 can 
now potentiate the transcription of the reporter gene which is under its control 
(Luban et al., 1995, Brachmann et al., 1997, and reviewed by Causier, 2004).   
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The advantages of the two-hybrid method for studying protein- protein 
interactions are that, it is an in vivo assay, which is simple to set up, requires 
little optimization, and is inexpensive to use (reviewed by Causier, 2004). On 
the other hand, the disadvantage of the yeast two-hybrid method is that it cannot 
detect interactions between more than two proteins (Ito et al., 2001, and Yu et 
al., 2008). 
1-2.1.8) The tandem affinity-purification method coupled to mass 
spectrometry (AP-MS): 
As discussed previously, important cellular functions, such as 
transcription, involve many polypeptides that assemble into multiprotein 
complexes of specific structures and compositions. Tandem-affinity purification 
coupled to mass spectrometry is a method that has proved invaluable in 
advancing the understanding of protein complexes (Gingras et al., 2007). This is 
a technique that was originally developed in yeast, but could be adapted to 
various organisms.  
Tandem affinity purification (TAP) is a technique that allows for the 
purification of protein complexes under native conditions (Rigault et al., 1999). 
This approach requires the fusion of a TAP-tag to the protein of interest either at 
the C- or N-termini. The tag consists of two IgG-binding units of protein A of 
the Staphylococcus aureus, a cleavage site for tobacco etch virus (TEV) 
protease, and a calmodulin binding peptide (Drakas et al., 2005).  Cell lines, 
carrying the tagged protein of interest, have to be created, from which 
macromolecular complexes can be isolated (Puig et al., 2001). The tagged 
protein must be expressed, in these cell lines, near physiological levels to 
minimize the rate of false positives (non-specific protein-protein interactions). 
This could be achieved by the use of an ecdysone-inducible expression system.  
The protein purification occurs in two steps using two different affinity 
columns (the IgG- and calmodulin-binding columns) under conditions that leave 
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proteins intact (Shevchenko et al., 2002). Purified protein complexes are then 
analyzed by mass spectrometry to determine the interacting partners.   
[Note: Details about how the cell lines are created, the ecdysone- 
inducible system, and how the protein complexes are purified are explained in 
section 3] 
The main advantage of the AP-MS strategy, other than the fact that 
the purification, itself, occurs under native conditions, is that it is an easy and 
a very efficient large-scale purification technique. On the other hand, the main 
disadvantage is that this technique does require the fusion of a tag to the 
protein of interest which might obscure binding of the protein to its 
interacting partners. In addition, the tag might not be sufficiently exposed to 
allow for the binding of the protein complex to the affinity beads. Another 
problem that might be encountered is that the tagged protein or its interacting 
partners might be cut by the TEV protease, although this is unlikely to be 
frequent (Puig et al., 2001).  
 
 
 
 
 
 
 
 
 
32 
 
Section 2: The Project and its objective 
 
2-1) Previous work in Dr. Coulombe’s laboratory: 
Over the past years, Dr. Benoit Coulombe’s laboratory has been 
interested in describing protein complexes and mapping their interaction 
networks in human cells. The project started with the purification of 
components of the RNAPII machinery. The TAP method was chosen to achieve 
the purification of the proteins of interest, coupled to mass spectrometry 
analysis and computational tools to build the interaction maps. 
The project started with the affinity purification of 32 TAP- tagged 
proteins, resulting in a network of 820 protein- protein interactions in which we 
have high confidence (refer to Figure 4). This network includes many 
transcription factors, as expected, RNA processing factors, which is also 
expected since the RNA processing machinery is known to interact with the 
RNAPII machinery. The network also included several proteins involved in 
modulating the formation of protein complexes amongst which were four 
previously uncharacterized proteins that were named RNAPII associated 
proteins (RPAPs), RPAP1, RPAP2/C1ORF82, RPAP3/FLJ21908 and XAB1 
(refer to Figure 5). These proteins are positioned at the interface between the 
RNAPII and a group of complexes such as the prefoldin complex, and the 
AAA+ chaperone-like ATPase RUVBL1 and RUVBL2, amongst other 
regulatory complexes. These RPAPs- XAB1 (XAB1 is also referred to as 
GPN1) proteins have also been observed to interact with some previously 
uncharacterized proteins (presented as yellow squares in Figure 5) such as 
MGC14560/ GPN3, LOC116143/ WDR92, NOP17/ PIH1D1, and PDRG1 
(Jeronimo et, al., 2007). 
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Figure 4: The network of protein interactions involving the RNAPII basal 
transcription machinery according to Jeronimo et al., 2007. 
Overview of the 820 high-confidence interactions obtained from 32 
affinity- purified proteins. 
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Figure 5: Network highlighting the interactions of RPAPs-XAB1 with 
RNAPII, the regulatory complexes integrator and mediator and a group of 
proteins with chaperone/scaffolding activity (Jeronimo et, al., 2007) 
Arrows point from bait to target. The TCP-1 ring chaperone complex is 
not shown in this graph. 
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2-2) Objective of my project: 
The aim of my project is to pursue the laboratory’s survey of soluble 
human protein complexes containing components of the transcription 
machineries. This will be achieved by purifying eight newly-identified RNAPII 
interaction partners using the TAP method and further defining their interaction 
network and their connections with RNAPII. The data will serve to increase the 
precision of our protein interaction map of the RNAPII machinery, thereby 
providing a clearer picture of the molecular pathways that regulate this 
important enzyme. This knowledge is important since the deregulation of 
RNAPII activity could lead to diseases such as cancer and genetic disorders.  
Four of the chosen RNAPII interaction partners are proteins of unknown 
function, namely MGC14560/GPN3, LOC116143/WDR92, PDRG1, 
NOP17/PIH1D1, which were observed to be interaction partners of the RPAPs-
XAB1/GPN1.  It was also observed that components of the prefoldin complex 
along with components of the TCP-1 ring complex also interacted with RPAPs-
XAB/GPN1, mainly RPAP2, RPAP3 and XAB1/GPN1. Therefore, PFDN2 of 
the prefoldin complex, and CCT4 and CCT5 of the TCP-1 ring complex, were 
chosen for TAP purification and mass spectrometry analysis. What was also of 
interest to us is the fact that four of the chosen proteins for TAP purification, 
mainly WDR92, PIH1D1, PDRG1, and PFDN2, were reported to be members 
of the URI/Prefoldin complex (Sardiu et al., 2007), which by itself has no 
specific function until now (The URI/Prefoldin complex will be discussed later 
on in section 4). The last protein chosen for TAP purification was the 
KIAA0406 protein observed to be an interaction partner of the AAA+ 
chaperone-like ATPases RUVBL1 and RUVBL2.  
My project mainly consisted of generating human cell lines expressing 
Tandem Affinity Peptide (TAP)-tagged versions of these eight RNAPII-
interacting partners, purifying the protein complexes using tandem affinity 
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chromatography, identifying the interaction partners using mass spectrometry, 
and applying specific computational tools to build the interaction networks.  
Information such as these will help to shed some light not only on the 
role these chosen proteins might playing in mammalian cells and the effects 
they might have on regulating the activity and assembly of RNAPII, but also on 
the role the URI/Prefoldin complex might be playing in human cells by 
purifying four of its members (WDR92, PIH1D1, PDRG1, and PFDN2) using 
the TAP method.  
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Section3: Materials and Methods 
3-1) The TAP purification method: 
TAP (Tandem Affinity Peptide) purification is a double affinity 
purification approach used to purify protein complexes under native conditions 
in cells. This technique has been optimized in our lab for the purification of 
soluble protein complexes in mammalian cells. The TAP method (summarized 
in Figure 6) consists of four main steps; 
1) Constructing a vector encoding the protein of interest fused at its C-
terminus to the double affinity tag. 
2) Creating human cell lines carrying the tagged protein. 
3) Purifying the complex in which the tagged protein is present by 
double affinity purification. 
4) Identifying the interaction partners of the protein of interest by mass 
spectrometry. 
Once the interacting partners have been identified, computational tools 
are applied to select high confidence interactions. It is worth mentioning that, it 
is crucial to achieve near physiological level of the tagged protein in the human 
cell line, therefore, avoiding an overexpression of the protein that can lead to 
non-specific protein interactions, and thus, measuring the rate of false positives. 
This is why a system is needed in which the expression of the tagged protein is 
under the control of an inducer. The system used in our lab is the ecdysone-
inducible expression system (Figure 7), where the EcR293s cells containing the 
plasmid, pVgRXR, constitutively express the retinoic acid receptor (RXR), the 
ecdysone receptor (VgEcR) that contains the transactivation domain of Vp16, 
and the bleocin resistance gene. In the presence of the inducer (Ponasterone A), 
RXR and VgEcR heterodimerize and bind to the specific ecdysone response 
element (E/GRE) found on the pMZI vector, therefore, inducing the expression 
of the fused protein of interest.   
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Figure 6: Schematic representation of the TAP procedure 
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Figure 7: Schematic representation of the ecdysone- inducible system in 
the mammalian EcR293 cells  
The upper part represents the vector, present in the EcR293 cells, is the 
vector encoding the retinoic acid receptor (RXR) and the ecdysone 
receptor (VgEcR), both of which are constitutively expressed. The lower 
part shows the vector is the pMZI vector carrying the gene of interest 
fused, C-terminally, to the TAP- tag vector, transfected into the 
mammalian EcR293 cells. 
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3.1.1) Constructing a vector encoding the protein of interest fused at its C-
terminus to the tag: 
The aim of this step is to create a vector in which the protein of interest 
is fused to the double affinity tag. To do so, the pMZI vector (refer to Figure 8) 
is used. This vector encodes a tandem affinity purification tag (TAP- tag) at its 
C-terminus, preceded by a multiple cloning site to which the cDNA of the 
protein of interest will be introduced. The TAP- tag itself consists of two 
binding sites, the Staphylococcus aureus protein A responsible for binding to 
the IgG beads, and the calmodulin binding peptide required for the binding to 
calmodulin beads, separated by the viral TEV protease cleavage site (refer to 
Figure 9). 
 
 
Figure 8: The pMZI vector  
This plasmid consists of two resistance sites to neomycin and ampicillin, a 
multiple cloning site and the TAP-tag (shown as a red rectangle) 
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Figure 9: Schematic representation of the tandem-affinity purification tag 
fused to a protein at its C-terminus 
 
In this project, the cDNA of eight different proteins were obtained from 
Invitrogen (for PFDN2, GPN3, PIH1D1 and WDR92), and Open Biosystems 
(for KIAA0406, PDRG1, CCT4 and CCT5), and had to be incorporated into the 
pMZI vector as follows: 
3-1.1.1) PCR 
PCR allows for the amplification of the cDNA of interest and the 
insertion of restriction sites at its 3' and 5' extremities. The restriction sites 
introduced were Xho1 and Not1 for PFDN2, PIH1D1, KIAA0406, PDRG1, 
WDR92, CCT4 and CCT5, and Sal1 and Not1 for GPN3. The PCR reactions 
were performed using either the Pfu turbo DNA polymerase (Stratagene) or the 
Phusion Hot Start DNA polymerase (Finnzymes). For PFDN2, PIH1D1 and 
WDR92, their PCR reactions (of a total volume of 50μl each) were performed 
using the Pfu turbo DNA polymearase and consisted of: 1ng of DNA, 1.75 μl of 
each forward and backward (10 μM) primers specific to the cDNA of interest, 
0.75 μl of (10 mM) dNTPs, 1 μl of the Pfu turbo DNA polymerase, 5 μl of the 
Pfu turbo (10x) buffer. As for KIAA0406, PDRG1, GPN3, CCT4 and CCT5, 
their PCR reactions ( of a total volume of 50 μl each) were performed using the 
Phusion Hot Start DNA polymerase, and consisted of: 1ng of DNA, 1.75 μl of 
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each forward and backward (10 μM) primers specific to the cDNA of interest, 
0.75 μl of (10 mM) dNTPs, 1 μl of the Phusion Hot Start DNA polymerase, 10 
μl of the Phusion buffer (5x). The PCR was run under the following conditions; 
For the Phusion Hot start DNA polymerase: 98°C for 30 secs, 98°C for 10 secs, 
(Tm- 5)°C for 30 secs, 72°C for 30 secs/ Kb, then the last three steps are 
repeated 25 times, and then 72°C for 10 mins, and finally hold at 12°C. As for 
the Pfu turbo DNA polymerase: 95°C for 2 mins, 95°C for 30 secs, (Tm- 5)°C 
for 30 secs, 72°C for 1 min/Kb. The last three steps are repeated 30 times, and 
then 72°C for 10 mins, and finally hold at 12°C. 
3-1.1.2) Enzymatic digestion 
The PCR product is then purified using the Qiagen kit and digested with 
Xho1 and Not1 or Sal1 and Not1 from the New England Biolabs. Purified 
pMZI is also digested with Xho1 and Not1 or Sa1 and Not1. The digestion is 
performed for approximately sixteen hours using the buffer recommended by 
New England Biolabs. Finally the digested samples are run on a 1% agarose gel 
stained with ethidium bromide. Then a gel extraction is performed using the 
Qiagen gel extraction kit. A dilution of 1(DNA): 25 (water) for each sample, 
and the concentration is then measured using a spectrometer at an OD of 260 
nm. 
3-1.1.3) Ligation 
The ligation reaction is performed overnight at 4°C and consisted of 1 μl 
of the T4 DNA ligase (Invitrogen), 4 μl of the T4 ligase buffer (5X), 250 pmol 
of the digested cDNA of interest and 5 fmol of the digested pMZI vector.  
3-1.1.4) Transformation into XL-1 cells 
100 μl of competent bacterial cells (XL-1 cells) are added to 10 μl of the 
ligation sample and incubated for 30 mins on ice. Heat shock is then performed 
on the samples for 90 secs at 42°C and the samples are then incubated on ice 
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for 2 mins. 900 μl of LB medium is then added to the sample and the reaction is 
incubated for 1 hr, at 37°C, with agitation. The sample is then centrifuged to 
allow for the sedimentation of the cells and only a 50 μl of the supernatant is 
kept to suspend the cells and plate them on ampicillin plates (100 μg/ml of 
ampicllin). The plates are incubated overnight at 37°C. Minipreps are then 
prepared by adding to 5 ml of LB medium, 1 μl of ampicillin and one picked 
colony, this will allow the plasmid to grow to a bigger quantity. These 
minipreps are incubated overnight at 37°C with agitation and then miniprep 
purification is performed using the Qiagen kit and the samples are sequenced. 
 
3-1.2) Creating human cell lines carrying the tagged protein of interest: 
The goal of this step is to isolate stable human cell line that expresses 
the tagged protein, near physiological level, when induced with a specific 
concentration of ponasterone A, the inducer.  
EcR293s cells are grown in DMEM medium containing 10% FBS (fetal 
bovine serum), 2 mM glutamine, 100 μg/ml penicillin, 100 μg/ml streptomycin 
and 30 μg/ml of bleocin. Cells are grown 20-24 hrs in an incubator at 37°C and 
5% CO2, before transfection with a mixture of 500 μl of (2x) HeBs (a 0.5 mM 
Na2HPO4.7H2O, 274 mM NaCl, 54.5 mM HEPES, at a pH of 7.0) to which 8 
μg/μl of DNA, 61 μl of 2 M CaCl2 and 430 μl of H2O. This mixture is 
incubated for 10 mins before adding it to the EcR293 cells. 12-14 hrs later, the 
cells are harvested and transferred to a DMEM medium containing 10% FBS, 2 
mM glutamine, 100 μg/ml penicillin, 100 μg/ml streptomycin, 30 μg/ml bleocin 
and 300 μg/ml of geneticin. Clones that grow are isolated and transferred to 
other plates, containing medium with geneticin, to grow to larger quantities.  
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3-1.3) Screening tests: 
To test the expression of the tagged protein in the selected cell lines, 
cells are grown in medium with geneticin and are induced with 3 µM 
ponasterone A for approximately 24 hrs, and then the cells are lysed with a lysis 
buffer (0.1% Triton x-100, 0.1 M Tris-HCl pH8.0) and loaded on a 4-12% SDS 
gel that will be used in western blot. The antibody used is Pol II (C-21) sc-900 
from Santa Cruz, an affinity-purified rabbit polyclonal IgG raised against the 
CTD of the Rpb1 of RNA polymerase II of mouse origin.  Clones that express 
the tagged protein are then frozen and kept at -80°C for later TAP purification. 
 
3-1.4) Purifying the complex in which our protein of interest is present by 
double affinity purification: 
 Clones expressing the tagged protein of interest are grown in large 
quantities. These quantities are divided into two, a part which will be induced 
with 3 µM Ponasterone A for 42 hrs before harvest and a part which will not be 
induced, but will rather be used as a negative control to minimize false-
positives (such as non-specific binding of soluble proteins to either the IgG 
beads or the calmodulin beads). 
 Harvested cells are homogenized on ice to lyse the cells releasing the 
whole cellular extract. Homogenization is performed, manually, using two 
different buffers, 10 strokes with each. The first round of strokes is with 4/3 
volume of buffer A (4 ml of buffer A to 3 grams of cells) which consists of 10 
mM Hepes pH 7.9, 1.5 mM MgCl2, 10 mM of KCl, 0.5 mM of DTT, 0.5 mM of 
AEBSF and 1 tablet of complete EDTA-free (from Roche).  The second round 
of strokes is with 1 volume of buffer B which consists of 50 mM Hepes pH 7.9, 
1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM AEBSF, 1.26 M potassium acetate and 
glycerol. Ultracentrifugation is then performed on the samples for 3 hrs at a 
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speed of 37K and a temperature of 4°C, and then dialyses are performed 
overnight at 4°C in 3 liters of dialysis buffer (10 mM Hepes pH 7.9, 0.1 mM 
EDTA, 0.1 mM DTT, 0.1 M potassium acetate, 10% glycerol). 
3-1.4.1) First affinity column:  
 The whole cell extract sample is added to IgG beads (50 μl per 1 g of 
cells) washed with IPP buffer (10 mM Tris pH 8, 100 mM NaCl, 0.1% Triton 
X100 and 10% glycerol) and incubated for 1 hr at 4°C with rotation. The beads 
are then washed few times with the IPP buffer and added to a column and then 
washed with the TEV buffer (10 mM Tris pH 8, 100 mM NaCl, 0.1% Triton 
X100, 0.5 mM EDTA, 10% glycerol and 1 mM DTT). Finally the column is 
sealed at the bottom and TEV buffer is added to the beads and then 30 units (3 
μl for 1 g of cells) of TEV protease (Invitrogen) are added to liberate the 
proteins bound to the IgG beads. This mixture is incubated overnight at 4°C 
3-1.4.2) Second affinity column: 
 The eluate from the first column is added to 50 μl of calmodulin beads 
washed with CBB buffer (10 mM Tris pH 8, 100 mM NaCl, 1 mM Immidazole, 
1 mM magnesium acetate, 2 mM CaCl2, 0.1% Triton X100, 10% glycerol and 
10 mM β-mercaptoethanol). In the presence of CaCl2 the mixture is incubated, 
with rotation, at 4°C for 2 hrs. The beads are then transferred to a second 
column and washed a few times with the CBB buffer and finally are eluted, in 
two steps, with the CEB buffer which consists of 2 mM EGTA, a calcium 
chelating agent that will break the binding of the CBP to the calmodulin beads, 
helping the elution process. CEB buffer also consists of 10 mM Tris pH 8, 100 
mM NaCl, 1 mM Immidazole, 1 mM magnesium acetate and 10 mM β-
mercaptoethanol. 
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3-1.5) Identifying the interaction partners of the protein of interest by mass 
spectrometry: 
Once the screening tests are performed, the chosen cell lines, expressing 
the tagged proteins, are cultivated in larger quantities. For each cell lines, a 
quantity was induced with 3 µM Ponasterone A for 42 hours before harvest, 
and another quantity was cultivated in the absence of Ponasterone A, and was 
used as a negative control to eliminate false-positives, as discussed earlier in 
section 3. The cells are then harvested and lysed, and the tagged proteins 
“protein complexes” are purified, following the protocol described in section 3, 
in the absence of detergent and high salt concentrations to preserve the integrity 
of the purified protein complexes (Coulombe et al., 2008). Once purified, the 
induced and non-induced samples are loaded on a 10% SDS gel stained with 
silver nitrate.  
Finally the gel is cut into slices for both induced (ponasterone A 
induced) and non-induced samples. This will facilitate the elimination of non- 
specific interactions from the induced sample. Samples are then digested with 
trypsin, preparing them for analysis by mass spectrometry (MS). MS analysis 
for this project was performed at IRCM Proteomics Discovery Platform by Dr. 
Denis Faubert. The mass spectrometer used is the tandem mass spectrometer 
(LC-MS/MS) with microcapillary reversed-phase high- pressure liquid 
chromatography coupled to an LCQ DecaXP (ThermoFinnigan), LTQ or LTQ-
Orbitrap (Thermoelectron) quadrupole ion trap mass spectrometer with a 
nanospray interface (Jeronimo et al., 2007). Mass spectrometry assigns a Mass 
Spectrometer (MS) score to each identified interacting partner.  
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3-1.6) Applying computational tools to select high confidence interactions: 
The list of interaction partners identified by MS for a given bait (tagged 
protein) is likely to contain a certain fraction of false positives as a result of 
indirect interactions, incorrect peptide identifications, contamination of gel 
lanes, etc… (Cloutier et al., submitted article). To select high- confidence 
interactions and minimize the number of false positives in our data set, our 
laboratory has developed a computational method that, first, filters out spurious 
interactions and, second, attributes an interaction reliability score (IRS) to each 
protein interaction detected by MS (Jeronimo et al., 2007). 
Therefore, for each purification, the non- specific interactions are 
filtered out by selecting proteins with an MS score that is at least 5 times higher 
in the induced sample compared to its equivalent non-induced sample 
(Jeronimo et al., 2007). Once the spurious interaction partners have been 
filtered out, each putative protein interaction remaining is assigned an IRS 
based on the MS score of the interaction partner, and the local topology of the 
interaction (Jeronimo et al., 2007).  The IRS is computed using the Naïve 
Bayes classifier, trained on a set of 135 positive interactions validated from the 
literature and a set of 53 negative interactions that were judged likely to be 
false-positives (Jeronimo et al., 2007). Finally, to select high confidence 
interactions, an IRS threshold (IRS above 0.6729) was chosen above which it is 
predicted that 17% of literature-supported interactions (false-negatives) will be 
missed, and 17% of interactions without literature support (false-positives) will 
be kept (Coulombe et al., 2008). Using the web-based software VisANT, 
protein interaction maps could be built, with the selected high confidence 
interactions, to serve in representing the data in a comprehensive manner 
(Jeronimo et al., 2007, Cloutier et al., submitted article).  
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Section 4: Results 
 
As mentioned earlier (in section 2), eight new RNAPII interaction 
partners have been purified using the tandem affinity purification methods to 
purify the complex in which they are present. Their interaction partners were 
then analyzed by MS and computational tools were finally applied to build their 
interaction maps. The eight proteins are GPN3, WDR92, PIH1D1, PDRG1, 
KIAA0406, PFDN2, CCT4 and CCT5. Following are the results of their 
purification. 
Note: 
a) The purification step, for three of the eight proteins (PIH1D1, CCT5   and 
PFDN2), was performed by Philippe Cloutier.  
b) Under screening tests, the western blots performed to check for the 
expression of the tagged protein in the selected cell lines are presented. Each 
lane, on the western blots, represents a different cell line except for the last lane 
which was loaded with a control sample (a cell line that has been already tested 
for the expression of the tagged protein of interest).  The red arrow points to the 
purified tagged protein, the blue arrow points to the purified tagged control 
protein, and the green arrow points to the cell line from which the tagged 
protein of interest was purified using the TAP method.  
Furthermore, the highest molecular weight bands, which are observed in figures 
11-B, 13-B (most clearly in lanes L2 and F3), represent Rpb1. This is due to the 
use of the C21 polyclonal antibody which is raised against the CTD of Rpb1 of 
RNAPII. As for the bands that appear at around 250 KDa in the same figures 
(also most clearly in lanes L2 and F3), these are unknowns but could be a non-
specific protein that is recognized by the C21 antibody.  
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c) For each TAP gel (silver stained SDS gel) presented next, the main 
interaction partners, as identified by MS, for each purified tagged protein are 
presented. A more complete list of interaction partners, following the filtration 
of non-specific interactions, is represented in the “Mascot results” figures. 
Furthermore, the red box on each TAP gel encloses the purified tagged protein. 
d) Whenever an interaction between two proteins is said to be “confirmed”,   
this means that both proteins co-purified with each other by TAP, and had an 
interaction IRS above threshold (0.6729), in each case. Furthermore, a purified 
protein is said to be “previously observed” to interact with another protein, 
referring to previous TAP purification experiments performed in our laboratory. 
 
4-1) Purification of GPN3/ MGC14560:  
 This protein is a GTPase that was observed to interact with RPAP2 and 
XAB1/GPN1 (Jeronimo et al., 2007). GPN3 stands for GPN-loop GTPase 3 
and thus, contains a GPN loop together with an “ATP-binding” domain 
(represented in Figure 10-A). Otherwise, nothing much is known about its 
function. 
 
Figure 10-A: Linear representation of GPN3 cDNA showing the conserved 
domain. 
 
 
 
 
 
MPRYAQLVMGPAGSGKSTYCATMVQHCEALNRSVQVVNLDPAAEHFNYSVMADIRELIEVDDVM
EDDSLRFGPNGGLVFCMEYFANNFDWLENCLGHVEDDYILFDCPGQIELYTHLPVMKQLVQQLE
QWEFRVCGVFLVDSQFMVESFKFISGILAALSAMISLEIPQVNIMTKMDLLSKKAKKEIEKFLD
PDMYSLLEDSTSDLRSKKFKKLTKAICGLIDDYSMVRFLPYDQSDEESMNIALQHIDFAIQYGE
DLEFKEPKEREDESSSMFDEYFQECQDE 
1 284 8 25
ATP_Bind_1 
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Figure 10-B: Screening test 
 
 
 
 
 
 
Figure 10-C: TAP gel 
 
 
 
51 
 
 
Figure 10-D: Mascot results 
 
Target IRS Target IRS Target IRS Target IRS 
HSPA1A 0.0 ACTA1 0.035 HIST1H1E 0.099 TUBB3 0.999 
HSPA1B 0.0 ACTA2 0.035 HIST1H1T 0.099 GPN1 1.0 
113425742 0.026 ACTB 0.035 TCOF1 0.143 HNRNPU 1.0 
GNPTG 0.026 ACTG1 0.035 POLR1D 0.165 POLR1A 1.0 
SLC32A1 0.026 ACTG2 0.035 POLR2I 0.225 POLR2A 1.0 
ZW10 0.026 A26C1A 0.037 HSPA2 0.523 POLR2B 1.0 
119572092 0.027 A26C1B 0.037 HSPA8 0.523 POLR2C 1.0 
MCM7 0.027 BAT2D1 0.040 POLR2F 0.890 POLR2H 1.0 
POLR2K 0.027 POLR1B 0.041 POLR3A 0.902 RPAP2 1.0 
POLR2L 0.027 PYGM 0.042 POLR3B 0.910 TUBA1A 1.0 
TUBA3C 0.027 ACTC1 0.043 POLR1C 0.945 TUBB2C 1.0 
TUBA3D 0.027 HIST1H1A 0.099 POLR2E 0.996   
TUBA3E 0.027 HIST1H1C 0.099 ATPBD1C 0.999   
POLR3D 0.028 HIST1H1D 0.099 HSPA6 0.999   
 
 
 
GPN3, as mentioned earlier, is an ATP-binding protein, of an unknown 
function that was previously picked up (co-purified) with purified RPAP2 and 
XAB1/GPN1 (also an ATP-binding protein) which, themselves, are proteins of 
an unknown function. Therefore, the purpose behind purifying GPN3 and 
identifying its interaction partners was not only to enrich our data set, but also 
to form an idea about the kind of a role this protein might be playing in 
regulating the human RNA polymerase II activity.    
TAP purification results of GPN3 show that it interacts with heat shock 
proteins, which are molecular chaperones that play a role in protein-protein 
interactions such as protein folding and intracellular transport of proteins. 
Furthermore, TAP purification results of both GPN3 and previous purification 
of XAB1/GPN1 show that these proteins also interact with actins and tubulins. 
XAB1/GPN1 have also been shown to interact with few subunits of the TCP-1 
ring complex, in previous TAP purification (Jeronimo et al., 2007), which is 
mainly involved in the folding of actins and tubulins.  
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4-2) Purification of WDR92/ LOC116143: 
 WDR92 is a protein that has been observed to interact with RPAP2, 
RPAP3, XAB1/GPN1 and RUVBL2 to mention a few (Jeronimo et al., 2007). 
WDR92 (WD Repeat domain 92) contains a WD40 repeat domain (represented 
in Figure 11-A), which are common structural module in eukaryotes. Proteins 
containing WD40 domains have a diverse range of biological functions, 
including signal transduction, cell cycle regulation, RNA splicing, and 
transcription (Saeki et al., 2006). WDR92 has been suggested to play a role as a 
novel modulator of apoptosis pathway since its overexpression in HEK 293 
cells potentiated apoptosis and caspase-3 activation induced by tumor necrosis 
factor-α (TNF- α) and cycloheximide (CHX) (Saeki et al., 2006). 
 
 
Figure 11-A: Linear representation of WDR92 cDNA showing the conserved 
domains 
 
   
MSAFEKPQIIAHIQKGFNYTVFDCKWVPCSAKFVTMGNFARGTGVIQLYEIQHGDLKLLREIEK
AKPIKCGTFGATSLQQRYLATGDFGGNLHIWNLEAPEMPVYSVKGHKEIINAIDGIGGLGIGEG
APEIVTGSRDGTVKVWDPRQKDDPVANMEPVQGENKRDCWTVAFGNAYNQEERVVCAGYDNGDI
KLFDLRNMALRWETNIKNGVCSLEFDRKDISMNKLVATSLEGKFHVFDMRTQHPTKGFASVSEK
AHKSTVWQVRHLPQNRELFLTAGGAGGLHLWKYEYPIQRSKKDSEGIEMGVAGSVSLLQNVTLS
TQPISSLDWSPDKRGLCVCSSFDQTVRVLIVTKLNKI 
 
 
 
 
WD40
1 15 348 35
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Figure 11-B: Screening test (the red boxes enclose the screening tests of 
WDR92). 
 
 
Figure 11-C: TAP gel 
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Figure 11-D: Mascot results  
 
Target IRS Target IRS Target IRS Target IRS 
ALB 0.0 SAT1 0.026 C19orf2 1.0 POLR3A 1.0 
HSPA1A 0.0 SUV420H2 0.026 CCT2 1.0 RPAP3 1.0 
HSPA1B 0.0 LOC730826 0.104 CCT3 1.0 RUVBL1 1.0 
HSPA6 0.0 TTC27 0.104 CCT4 1.0 RUVBL2 1.0 
PDRG1 0.0 UTP14A 0.104 CCT5 1.0 TCP1 1.0 
PFDN2 0.0 TTC6 0.106 CCT6A 1.0 TUBA1A 1.0 
PIH1D1 0.0 POLR2K 0.110 CCT6B 1.0 TUBB 1.0 
POLR2E 0.0 A26C1A 0.112 CCT7 1.0   
UXT 0.0 KIF3A 0.147 CCT8 1.0   
WDR92 0.0 TUBB1 0.185 HSPA8 1.0   
OPA1 0.025 GFAP 0.2 KIAA0406 1.0   
POLR2L 0.025 NCOA5 0.442 PFDN6 1.0   
SIGLEC11 0.025 PLG 0.442 POLR2B 1.0   
THEX1 0.025 CDO1 0.470 POLR2H 1.0   
 
 
 
 
TAP purification of WDR92 did confirm its interaction with RPAP3 
and RUVBL2 but not with RPAP2 and XAB1/GPN1. The interaction of 
WDR92 with RPAP3 was, furthermore, confirmed recently by a group in Osaka 
University, Japan, where V5-tagged WDR92 was subjected to affinity 
purification using V5 antibodies. Mass spectrometry analysis of their purified 
V5-tagged WDR92 identified RPAP3 as one of its interaction partners (Itsuki et 
al., 2008).  
 What was also interesting to observe, in our results, was the fact that the 
eight subunits of the TCP-1 ring complex, co-purified with WDR92. On the 
other hand the TAP purification of both CCT4 and CCT5 (presented below), 
which are components of the TCP-1 ring complex, did not yield WDR92 as an 
interaction partner. Further interaction partners obtained will be discussed later 
on when talking about the URI/Prefoldin complex.  
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4-3) Purification of PDRG1: 
 PDRG1 stands for p53 and DNA damage regulated 1, and does not 
contain any conserved domain. It was observed to be an interaction partner of 
RPAP3, XAB1/GPN1 and RUVBL2 (Jeronimo et al., 2007). PDRG1 mRNA 
has been shown to be upregulated by ultraviolet radiation (UV) and 
downregulated by tumor suppressor p53. In fact, analysis of the PDRG1 
promoter revealed the presence of Oct-1-binding element recognized by oct-1, a 
transcription factor that is activated by UV. Furthermore, a putative head-to–tail 
type p53-binding site was also found in the PDRG1 promoter (Luo, Huang, and 
Sheikh, 2003).  
 
 
 
Figure 12-A: Linear representation of PDRG1 cDNA 
 
 
 
MLSPEAERVLRYLVEVEELAEEVLADKRQIVDLDTKRNQNREGLRALQKDLSLSEDVMVCFGNM
FIKMPHPETKEMIEKDQDHLDKEIEKLRKQLKVKVNRLFEAQGKPELKGFNLNPLNQDELKALK 
VILKG 
 
 
 
 
 
 
No putative conserved domains 
1 133 
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Figure 12-B: Screening test 
 
 
Figure 12-C: TAP gel. 
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Figure 12-D: Mascot results 
Target IRS Target IRS Target IRS Target IRS 
PDRG1 0.0 VBP1 0.041 HIST1H1C 0.436 119600484 1.0 
SNRPB 0.0 RBM14 0.051 HIST1H1D 0.436 PFDN2 1.0 
SNRPD3 0.0 RBM22 0.056 HIST1H1E 0.436 PFDN6 1.0 
SNRPE 0.0 CYorf15A 0.104 ARHGEF12 0.442 PIH1D1 1.0 
SNRPN 0.0 TARDBP 0.111 BRD4 0.443 POLR2E 1.0 
CDH19 0.025 YTHDF2 0.119 SRI 0.500 RPAP3 1.0 
SFRS11 0.025 KLC1 0.127 CSNK2B 0.589 RUVBL1 1.0 
CYB 0.026 ARNT 0.144 LONP1 0.749 RUVBL2 1.0 
119606377 0.026 DDX39 0.154 PFDN1 0.999 TUBB2A 1.0 
SDCCAG1 0.026 HIST1H1T 0.280 HSPA5 1.0 TUBB2B 1.0 
ISPF6484 0.026 HIST1H1A 0.280 C19orf2 1.0 UXT 1.0 
HMG20B 0.027 PFDN5 0.430 LOC100131673 1.0 WDR92 1.0 
 
 
Tap purification of PDRG1 confirmed its interaction with RPAP3, 
XAB1/GPN1 and RUVBL2. What was also interesting to observe is that 
several of its most abundant interaction partners were prefoldin subunits, 
amongst other proteins which will be discussed later on, in the URI/Prefoldin 
complex section. 
 
4-4) Purification of NOP17/ PIH1D1: 
 PIH1D1 is an interaction partner of RPAP2, RPAP3, XAB1/GPN1, 
RUVBL1 and RUVBL2 (Jeronimo et al., 2007). PIH1D1 stands for PIH1 
domain containing 1, and thus contains a PIH1 domain. In yeast, the homologue 
of PIH1D1 is Pih1 which was reported to be a member of a complex called 
R2TP. The R2TP complex is composed of Pih1 of course, together with a 
protein called Tah1 and the helicases Rvb1 and Rvb2 (the yeast homologues of 
RUVBL1 and RUVBL2). This complex plays an important role in the correct 
accumulation of box C/D small nucleolar ribonucleoproteins.  
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Furthermore, it was observed that Pih1 is an unstable protein that is 
stabilized by the assistance of chaperones. The chaperone involved in 
stabilizing this protein in log-phase yeast cultures is still unknown. On the other 
hand, in the stationary-phase of cells (the stress-phase in yeast cells) Pih1 was 
shown to be stabilized by Tah1 and the Hsp90 chaperone (Zhao et al., 2008). 
 
Figure 13-A: Linear representation of PIH1D1 cDNA showing the conserved 
domain 
 
 
 
 
 
MANPKLLGMGLSEAEAIGADSARFEELLLQASKELQQAQTTRPESTQIQPQPGFCIKTNSSEGK
VFINICHSPSIPPPADVTEEELLQMLEEDQAGFRIPMSLGEPHAELDAKGQGCTAYDVAVNSDF
YRRMQNSDFLRELVITIAREGLEDKYNLQLNPEWRMMKNRPFMGSISQQNIRSEQRPRIQELGD
LYTPAPGRAESGPEKPHLNLWLEAPDLLLAEVDLPKLDGALGLSLEIGENRLVMGGPQQLYHLD
AYIPLQINSHESKAAFHRKRKQLMVAMPLLPVPS 
 
Figure 13-B: Screening test (the red box encloses the screening test of PIH1D1) 
 
1 290
PIH1
35 28
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Figure 13-C: TAP gel. 
 
 
Figure 13-D: Mascot results 
 
Target IRS Target IRS Target IRS Target IRS 
CCDC80 0.025 SPRR2D 0.031 A26C1A 0.165 TUBB8 1.0 
DHX40 0.025 SPRR2F 0.031 INTS9 0.443 119600484 1.0 
GCDH 0.025 SPRR2G 0.031 CHD3 0.472 LOC100131673 1.0 
KIAA1602 0.025 CYorf15A 0.104 TMTC3 0.473 PDRG1 1.0 
MYH10 0.025 POLE 0.104 POLR2A 1.0 PFDN2 1.0 
SMARCC1 0.025 KIF3A 0.105 POLR2E 1.0 WDR92 1.0 
CEP170 0.026 RNF103 0.105 HSPA5 1.0 PFDN6 1.0 
KLC2 0.026 MYO5B 0.110 RPAP3 1.0 PIH1D1 1.0 
RPL9 0.028 ACAA2 0.110 C19orf2 1.0 TUBA1A 1.0 
SPRR2A 0.029 PLG 0.112 RUVBL1 1.0 TUBB4 1.0 
SPRR2B 0.029 CKAP5 0.125 RUVBL2 1.0   
SPRR2E 0.029 NCKAP1 0.126 UXT 1.0   
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By TAP purifying PIH1D1, its interactions with RPAP3, RUVBL1 and 
RUVBL2 were confirmed. On the other hand, an interaction with either RPAP2 
or XAB1/GPN1 was not observed. Further identified interaction partners of 
PIH1D1 will be discussed next, in the URI/Prefoldin complex section 
 
4-5) Purification of PFDN2: 
 PFDN2 interacts mainly with RPAP3 in the network of protein 
complexes involving the human RNAPII transcription machinery (Jeronimo et 
al., 2007). As mentioned previously in this introduction, PFDN2 is a subunit of 
the prefoldin complex which plays a role as a cochaperone delivering cytosolic 
proteins to the TCP-1 ring complex for proper folding. PFDN2 contains a 
prefoldin_2 domain.   
 Recently, PFDN2, WDR92, PIH1D1 and PDRG1, have all been 
reported to be members of the URI/Prefoldin complex. This complex does not 
have any known function until now but as reported, it is composed of 10 
proteins, including PFDN2, WDR93, PIH1D1, PDRG1, RPAP3, UXT, URI, 
PFDN6, Rpb5/POLR2E and HKE2 (Saridiu et al., 2007). 
 
Figure 14-A: Linear representation of PFDN2 cDNA showing the conserved 
domain 
 
 
 
MAENSGRAGKSSGSGAGKGAVSAEQVIAGFNRLRQEQRGLASKAAELEMELNEHSLVIDTLKEV
DETRKCYRMVGGVLVERTVKEVLPALENNKEQIQKIIETLTQQLQAKGKELNEFREKHNIRLMG
EDEKPAAKENSEGAGAKASSAGVLVS 
 
1 24 127 155
Prefoldin_2 
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Figure 14-B: Screening test 
 
The lowest molecular weight band that appears in lane P16 is an unknown 
which could be the result of degradation or splicing of the tagged protein of 
interest. 
Figure 14-C: TAP gel. 
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Figure 14-D: Mascot results 
Target IRS Target IRS Target IRS Target IRS 
VBP1 0.0 TSPYL2 0.025 C15orf15 0.109 HNRNPA1 1.0 
PFDN1 0.0 XPA 0.025 SYNE2 0.111 HSPA2 1.0 
PFDN2 0.0 TRIP12 0.026 MORC1 0.112 LOC283767 1.0 
PFDN5 0.0 DDX41 0.027 DNAH9 0.124 PCBP2 1.0 
TUBA1B 0.0 NRBF2 0.027 SOS1 0.125 PDRG1 1.0 
AP3B1 0.025 TET2 0.027 LOC641515 0.136 PFDN4 1.0 
ATP9B 0.025 TRIM4 0.027 HNRNPR 0.143 PFDN6 1.0 
C11orf63 0.025 C3 0.027 MYH11 0.290 PIH1D1 1.0 
FAM133A 0.025 MYH14 0.038 KIN 0.391 POLR2E 1.0 
ICA1 0.025 KIF5B 0.051 CKAP5 0.443 RPAP3 1.0 
ITSN2 0.025 ANAPC1 0.104 Gcom1 0.447 RUVBL1 1.0 
KIAA1826 0.025 CERKL 0.104 TCP1 0.470 RUVBL2 1.0 
KIF3C 0.025 LOC730826 0.104 CUX1 0.498 TUBB4 1.0 
LARP2 0.025 FLJ39660 0.104 HNRNPU 0.979 UXT 1.0 
MRPL52 0.025 SFRS12IP1 0.104 HNRNPA2B1 0.989   
MYH3 0.025 RBM33 0.104 TUBB2C 0.999   
NSBP1 0.025 SH2D4B 0.104 TUBB 0.999   
PRKCSH 0.025 GBP2 0.106 C19orf2 1.0   
RPUSD2 0.025 GOLGA1 0.108 LOC100131673 1.0   
SND1 0.025 WDR87 0.109 CCT4 1.0   
 
 
As mentioned earlier, PFDN2 is a component of the prefoldin complex, 
the co-chaperone that helps deliver cytosolic proteins to the TCP-1 ring 
complex. The reason PFDN2 was chosen for TAP purification is because of the 
fact that it was previously observed to interact with RPAP3, and we wanted to 
confirm this interaction. TAP purification results of this protein did not yield 
any new interaction partners and, as expected, most of its abundant interaction 
partners are prefoldin subunits, amongst other proteins including RPAP3, thus, 
confirming the interaction between the two proteins. 
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4-6) Purification of the URI/Prefoldin complex: 
 WDR92, PIH1D1, PDRG1 and PFDN2 together with eight other 
proteins, mainly RPAP3, UXT, PFDN6, RUVBL1, RUVBL2, URI, RPB5, and 
POL3A, are all proteins reported to be members of a complex called the 
URI/Prefoldin complex (Sardiu et al., 2007), which until now has no specific 
function. Tap purification of WDR92, PIH1D1, PDRG1, PFDN2 (results 
presented above), and previous TAP purification of RPAP3, PFDN6 (results 
reported in Jeronimo et. al., 2007), and UXT (by Philippe Cloutier, unpublished 
data), resulted in the purification of almost all of the components of the 
URI/Prefoldin complex except one which is the POL3A. Several hypotheses 
could be made about the role the URI/Prefoldin complex might be playing in 
human cells, from the purification of several of its components in this project 
and other purifications performed in our laboratory. Most components of the 
URI/Prefoldin complex have been tagged in our laboratory, including PFDN6, 
UXT, RPAP3, RUVBL1, RUVBL2, and RPB5, and the hypotheses concerning 
this complex are discussed later in the “Discussion” section. 
  
4-7) Purification of CCT4 and CCT5: 
 These two proteins are components of the TCP-1 ring complex 
discussed earlier which were observed to interact mainly with XAB1/GPN1 
(Jeronimo et al., 2007). The TCP-1 ring complex is a chaperone that assists in 
the folding of cytosolic proteins, mainly actin and tubulin. CCT5 contains a 
TCP1_epsilon conserved domain, and CCT4 contains a TCP1_delta conserved 
domain. 
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Figure 15-A.1: Linear representation of CCT4 cDNA showing the conserved 
domain 
 
 
 
 
MPENVAPRSGATAGAAGGRGKGAYQDRDKPAQIRFSNISAAKAVADAIRTSLGPKGMDKMIQDG
KGDVTITNDGATILKQMQVLHPAARMLVELSKAQDIEAGDGTTSVVIIAGSLLDSCTKLLQKGI
HPTIISESFQKALEKGIEILTDMSRPVELSDRETLLNSATTSLNSKVVSQYSSLLSPMSVNAVM
KVIDPATATSVDLRDIKIVKKLGGTIDDCELVEGLVLTQKVSNSGITRVEKAKIGLIQFCLSAP
KTDMDNQIVVSDYAQMDRVLREERAYILNLVKQIKKTGCNVLLIQKSILRDALSDLALHFLNKM
KIMVIKDIEREDIEFICKTIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGKLLKITGCASPGK
TVTIVVRGSNKLVIEEAERSIHDALCVIRCLVKKRALIAGGGAPEIELALRLTEYSRTLSGMES
YCVRAFADAMEVIPSTLAENAGLNPISTVTELRNRHAQGEKTAGINVRKGGISNILEELVVQPL
LVSVSALTLATETVRSILKIDDVVNTR 
 
 
 
Figure 15-A.2: Linear representation of CCT5 cDNA showing the conserved 
domain 
 
 
 
 
MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDK
DGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGI
HPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNA
VLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFE
PPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLP
AVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVT
IFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAM
RAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIG
KKQQISLATQMVRMILKIDDIRKPGESEE 
 
 
 
TCP1_ Delta 
1 53925 538
1 54110 535
TCP1_ Epsilon 
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Figure 15-B.1: Screening tests for CCT4. 
 
 
Figure 15-B.2: Screening tests for CCT5. 
 
The lowest molecular weight bands which appear in lanes C5 and C6 are 
unknowns, but could be the result of degradation or splicing of the tagged 
protein of interest. 
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Figure 15-C.1: TAP gel for CCT4. 
 
 
Figure 15-C.2: Tap gel for CCT5. 
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Figure 15-D.1: Mascot results for CCT4 
 
Target IRS Target IRS Target IRS Target IRS 
CCT4 0.0 HAS1 0.1263 NCOA5 0.893 LONP1 1.0 
HRNR 0.029 CDO1 0.1264 RPL22 0.941 CCT6A 1.0 
PLG 0.029 LOC391656 0.167 CCT6B 0.9902 PCBP2 1.0 
ACTB 0.0446 HIST1H1D 0.198 HSPA6 0.999 CCT7 1.0 
ACTG1 0.0446 HIST1H1C 0.533 CCT2 1.0 CCT8 1.0 
PCBP1 0.122 HIST1H1E 0.720 CCT3 1.0 TCP1 1.0 
DLK1 0.1260 ARHGEF12 0.8901 CCT5 1.0   
 
 
Figure 15-D.2: Mascot results for CCT5 
 
Target IRS Target IRS Target IRS Target IRS 
CCT5 0.0 PRIC285 0.029 TRAP1 0.264 DNM2 1.0 
TUBA1A 0.0 TFDP1 0.029 PHGDH 0.292 HNRNPU 1.0 
TUBA1B 0.0 TXNDC9 0.029 KIF5A 0.299 HSP90AA1 1.0 
ACTB 0.0 CTR9 0.030 XPO5 0.353 HSPA1A 1.0 
ACTG1 0.0 DYNC1H1 0.030 TUBB8 0.375 HSPA1B 1.0 
TUBA1C 0.0 KCTD19 0.031 TUBB2A 0.457 KHSRP 1.0 
TUBB 0.0 MOBKL1A 0.031 CDO1 0.463 KPNA2 1.0 
BLM 0.025 MOBKL1B 0.031 C8orf42 0.565 KPNB1 1.0 
LOC150759 0.025 TIMM13 0.033 CSE1L 0.606 LONP1 1.0 
LYST 0.025 PSMA5 0.042 TUBA3C 0.641 PCBP1 1.0 
PDCL3 0.025 KIF5B 0.086 XPO1 0.641 PDCD5 1.0 
RC3H2 0.025 KIF5C 0.086 EIF4A2 0.822 RQCD1 1.0 
SPAG17 0.025 NUDT21 0.091 CAND1 0.901 RUVBL1 1.0 
THBS1 0.025 DIAPH1 0.104 EIF4A1 0.970 RUVBL2 1.0 
TRPA1 0.025 KLHL3 0.104 HSPA2 0.977 TUBB2C 1.0 
113422833 0.026 THOC4 0.104 INF2 0.999 TUBB3 1.0 
ABCB1 0.026 TRIP12 0.104 BAT2D1 1.0 TUBB4 1.0 
C3orf26 0.026 SAC 0.105 TCP1 1.0 TUBB6 1.0 
RBM19 0.026 119583598 0.108 CCT2 1.0   
SEPX1 0.026 TUBB2B 0.109 CCT3 1.0   
SMC2 0.026 FANC1 0.111 CCT4 1.0   
CARS 0.027 EEF1A2 0.125 CCT6A 1.0   
CHPF 0.027 LOC391656 0.134 CCT6B 1.0   
RPL9 0.027 HAS1 0.144 CCT7 1.0   
UCK1 0.027 RBM14 0.201 CCT8 1.0   
UCK2 0.027 TUBA3D 0.207 CKAP5 1.0   
ZC3H12C 0.027 TUBA3E 0.207 DDX42 1.0   
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As mentioned earlier, CCT4 and CCT5 are components of the TCP-1 
ring complex responsible for the folding of mainly actin and tubulin. 
Considering our hypothesis of the role of both XAB1/GPN1 and GPN3 in the 
formation of microtubules (discussed earlier in “Purification of GPN3” 
section), it was of interest to us to confirm the interaction of XAB1/GPN1 with 
TCP-1 ring complex. CCT4 and CCT5 were the chosen subunits since they 
both were shown to co-purify with the XAB1/GPN1 protein. TAP purification 
of both CCT4 and CCT5 did confirm their interaction with XAB1/GPN1. 
 It was of no surprise, of course, to find that the most abundant 
interaction partners of both CCT4 and CCT5 were subunits of the TCP-1 ring 
complex. On the other hand, the Tap purification of CCT5 did yield a new 
interaction partner, the PDCD5 protein.  
 
4-8) Purification of KIAA0406: 
 KIAA0406 does not contain any identifiable conserved domains. It has 
been observed to be an interaction partner of mainly RUVBL1 and RUVBL2 
(Jeronimo et al., 2007), but nothing much is known about the kind of a function 
it might be playing in human cells. 
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Figure 16-A: Linear representation of KIAA0406 cDNA 
 
 
 
 
MAVFDTPEEAFGVLRPVCVQLTKTQTVENVEHLQTRLQAVSDSALQELQQYILFPLRFTLKTPG
PKRERLIQSVVECLTFVLSSTCVKEQELLQELFSELSACLYSPSSQKPAAVSEELKLAVIQGLS
TLMHSAYGDIILTFYEPSILPRLGFAVSLLLGLAEQEKSKQIKIAALKCLQVLLLQCDCQDHPR
SLDELEQKQLGDLFASFLPGISTALTRLITGDFKQGHSIVVSSLKIFYKTVSFIMADEQLKRIS
KVQAKPAVEHRVAELMVYREADWVKKTGDKLTILIKKIIECVSVHPHWKVRLELVELVEDLLLK
CSQSLVECAGPLLKALVGLVNDESPEIQAQCNKVLRHFADQKVVVGNKALADILSESLHSLATS
LPRLMNSQDDQGKFSTLSLLLGYLKLLGPKINFVLNSVAHLQRLSKALIQVLELDVADIKIVEE
RRWNSDDLNASPKTSATQPWNRIQRRYFRFFTDERIFMLLRQVCQLLGYYGNLYLLVDHFMELY
HQSVVYRKQAAMILNELVTGAAGLEVEDLHEKHIKTNPEELREIVTSILEEYTSQENWYLVTCL
ETEEMGEELMMEHPGLQAITSGEHTCQVTSFLAFSKPSPTICSMNSNIWQICIQLEGIGQFAYA
LGKDFCLLLMSALYPVLEKAGDQTLLISQVATSTMMDVCRACGYDSLQHLINQNSDYLVNGISL
NLRHLALHPHTPKVLEVMLRNSDANLLPLVADVVQDVLATLDQFYDKRAASFVSVLHALMAALA
QWFPDTGNLGHLQEQSLGEEGSHLNQRPAALEKSTTTAEDIEQFLLNYLKEKDVADGNVSDFDN
EEEEQSVPPKVDENDTRPDVEPPLPLQIQIAMDVMERCIHLLSDKNLQIRLKVLDVLDLCVVVL
QSHKNQLLPLAHQAWPSLVHRLTRDAPLAVLRAFKVLRTLGSKCGDFLRSRFCKDVLPKLAGSL
VTQAPISARAGPVYSHTLAFKLQLAVLQGLGPLCERLDLGEGDLNKVADACLIYLSVKQPVKLQ
EAARSVFLHLMKVDPDSTWFLLNELYCPVQFTPPHPSLHPVQLHGASGQQNPYTTNVLQLLKEL
Q 
 
Figure 16-B: Screening test 
 
1
No putative conserved domains 
108
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The lowest molecular weight bands which appear in lanes K5 and K7 are 
unknowns, but could be due to degradation or splicing of the tagged protein of 
interest. 
 
 
Figure 16-C: TAP gel. 
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Figure 16-D: Mascot results 
 
Target IRS Target IRS Target IRS Target IRS 
KIAA0406 0.0 TCOF1 0.029 HIST1H2AB 0.958 HIST1H2BH 1.0 
113426227 0.025 ELAVL2 0.035 HIST1H2AC 0.958 TUBB4 1.0 
113426576 0.025 LOC653781 0.044 HIST1H2AE 0.958 HIST1H2BK 1.0 
CAMK2G 0.025 HNRNPA3 0.081 HIST3H2A 0.958 HIST1H2BL 1.0 
ARID5B 0.025 HNRPA3 0.081 HIST1H1C 0.999 HIST1H2BM 1.0 
BARD1 0.025 TOP2A 0.082 HIST1H1D 0.999 HIST1H2BN 1.0 
CAMK2B 0.025 HSP90AA2 0.112 HIST1H1E 0.999 HIST1H4A 1.0 
TTBK1 0.025 HSP90AB1 0.112 HIST1H2BB 0.999 HIST1H4C 1.0 
hCG177972
9 0.025 DCD 0.162 HIST1H2BJ 0.999 HIST1H4E 1.0 
METTL3 0.025 HNRPH1 0.175 HIST1H2BO 0.999 RUVBL1 1.0 
AZGP1 0.026 HNRPH2 0.175 HIST1H3I 0.999 RUVBL2 1.0 
C1orf163 0.027 EIF4A1 0.264 HIST2H2BE 0.999 HIST2H2BF 1.0 
CCDC102A 0.027 EIF4A2 0.264 H2BFS 1.0 HIST2H4A 1.0 
GATAD2A 0.027 HSPA5 0.359 HIST1H2BC 1.0   
GATAD2B 0.027 HSP90AA1 0.463 HIST1H2BD 1.0   
DLK1 0.027 MATR3 0.559 HIST1H2BE 1.0   
HSP90AB2
P 0.027 H2AFV 0.719 HIST1H2BG 1.0   
 
 
 KIAA0406 is a protein of an unknown function, as mentioned earlier, 
which was shown to interact with RUVBL1 and RUVBL2, both of which are 
members of the AAA+ family (ATPases associated with different cellular 
activities), in a previous purification performed in our lab. RUVBL1 and 
RUVBL2 are proteins usually found in a number of nuclear complexes, such as 
chromatin modifying complexes, transcription-activating complexes, and small 
nucleolar ribonucleoprotein complexes (snoRNPs) (Puri et al., 2007). 
  
 By purifying KIAA0406, its interaction with both RUVBL1 and 
RUVBL2 was confirmed, since both of these proteins co-purified with it.  It 
was also observed that the most abundant interaction partners that co-purified 
with this protein are mainly histones.  
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4-9) Graphical representation of the presented TAP results in this project:  
 Finally, using the web-based software VisANT, an interaction map 
showing all of the validated interactions for each purified protein can be 
generated and is shown in Figure 17 (next page). This figure represents only the 
interaction for which the IR score exceeded the threshold 0.6729 (validated 
interactions). The RPAP-GPN1 complex, the URI/Prefoldin complex, subunits 
of all three RNA polymerases amongst other complexes are also presented on 
this graph. 
Note for Figure 17: Yellow nodes: TAP purified proteins. Blue nodes: Protein 
TAP purified previously in the laboratory. Green nodes: Identified interaction 
partners. Grey arrows: Points to targets of the previously purified proteins in 
our laboratory. Blue arrows point to the interaction partners of the 8 TAP 
purified proteins mentioned in this project. Red arrows are interactions amongst 
the URI/Prefoldin complex. 
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          Figure 17: Interaction map showing the eight purified proteins, in this project, and their high confidence interactions 
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Section 5: Discussion 
 
5-1) The AP-MS method: 
 
 The AP-MS method has proven to be an efficient tool for the 
characterization of protein complexes and the identification of protein 
interaction partners. Amongst various possible strategies of conducting AP-MS, 
the Tandem Affinity Purification (TAP) technique coupled to mass 
spectrometry has been the method of choice in our laboratory for the 
purification of protein complexes in mammalian cells (Cloutier et al., submitted 
article). 
 
As discussed earlier, in section 1-2.2.2, the AP-MS method does have 
few limitations that must be overcome or resolved to obtain the most accurate 
results. For example, it is known that affinity chromatography is a technique that 
is prone to generate high levels of contaminants. By using TAP as a method of 
purification in our laboratory, we are able to reduce the amount of contaminants 
from the affinity purified eluate, but the caveat is that weak, transient 
interactions will more readily be disrupted, leading to the loss of interesting 
interaction partners (Cloutier et al., submitted article). Furthermore, the use of 
sensitive, high- accuracy mass spectrometry, in our laboratory, coupled to the 
TAP technique also lead to a significant decrease in the rate of false positives 
that are normally generated. Also by making sure of using an expression system, 
such as the ecdysone- inducible system used in our laboratory, that avoids the 
overexpression of the tagged protein, has been shown to minimize the 
occurrence of spurious protein- protein interactions in our datasets (Cloutier et 
al., submitted article). Finally, to increase the confidence in the protein- protein 
interaction datasets in our laboratory, the development of a computational 
algorithm trained to minimize the rate of false positive and false negative 
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interactions has been shown to be very powerful and useful (Cloutier et al., 
submitted article). 
 
5-2) Purification of the 8 newly-identified RNAPII interaction partners: 
 
 The study of protein-protein interactions and protein complexes has 
proved to be essential for understanding how cells function in normal 
conditions; and, consequently, is useful to reveal novel targets which are 
paramount to the development of new drugs to treat diseases (Al-Khoury R, and 
Coulombe B, 2009). 
 
 In efforts of pursuing our navigation on the network of protein 
complexes forming the transcription machinery in the soluble fraction of human 
cells, eight RPAPs-XAB1 newly-identified interaction partners were chosen for 
TAP purification, mainly GPN3, WDR92, PDRG1, PFDN2, PIH1D1, 
KIAA0406, CCT4 and CCT5.  
 
 As can be observed in the section 4, purification of these eight 
proteins helped us in further enriching our data set, and confirming previously 
identified interactions. For most of proteins of an unknown function such as, 
GPN3, and KIAA0406, PDRG1, PIH1D1 and WDR92, identifying their 
interaction partners helped us in forming an idea about the kind of a role they 
might be playing in mammalian cells.  
 
 For example, in the case of GPN3’s purification, presented in section 
4-1, and previous purification of RPAP2 and XAB1/GPN1, presented in 
Jeronimo et al., 2007, most of their abundant interaction partners included 
subunits of RNAPI, RNAPII and RNAPIII (except for RPAP2 which was only 
observed to interact with subunits of RNAPII and RNAPIII). Knowing that it is 
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still unclear until now where and in what manner do the subunits of each of the 
three RNA polymerases come together to form the different enzymes, it is 
reasonable to suggest that GPN3, together with RPAP2 and XAB1/GPN1, could 
be playing a role in the assembly of the RNA polymerases. As mentioned 
earlier, in section 4-1, both GPN3 and XAB1/GPN1 were observed to interact 
with actins and tubulins, and subunits of the TCP-1 ring complex (in the case of 
XAB1/GPN1). It is, therefore, also reasonable to assume a role for these 
proteins (GPN3 and XAB1/GPN1) in, perhaps, the formation of microtubules. 
The role of XAB1/GPN1 is currently being investigated in our laboratory. 
 
 As for the KIAA0406 protein, the fact that it was observed to interact 
with both RUVBL1 and RUVBL2 which, as mentioned previously, are found in 
chromatin modification complexes, and the fact that most of its interaction 
partners were observed to be histones, it is reasonable to assume that this 
protein might be involved somehow in chromatin modification. 
 
 CCT4 and CCT5 are two proteins of known function, as subunits of 
TCP-1 ring complex chaperone, which have been chosen for TAP purification. 
Although CCT4 did not yield any unexpected interaction partners other than the 
subunits of the TCP-1 ring complex, CCT5 did yield an unexpected interaction 
partner, the PDCD5 protein.  
 
 PDCD5 (programmed cell death 5) is a protein that is expressed at 
higher levels in tumor cells, compared to normal cells, during apoptosis. 
Although its exact function is still not defined, it is thought to regulate both 
apoptotic and non-apoptotic programmed cell death (Liu et al., 2005). The 
PDCD5 protein is distributed in both the nucleus and the cytoplasm, but once 
apoptosis is induced, its level increases, and by relocation from the cytoplasm, it 
accumulates in the nucleus (Chen et al., 2001). The mechanism by which 
PDCD5 crosses the nuclear envelope and functions in the nucleus is still 
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unclear. But it is thought that the N-terminal α-helix of this protein may play 
some role in its translocation to the nucleus of target cells. The N-terminal 
residues of PDCD5 tend to form a stable α-helical structure independently of 
the core of the protein. Apoptosis activity assay indicates that the deletion of the 
N-terminal α-helix of PDCD5 attenuates the apoptosis-promoting effects of this 
protein (Liu et al., 2005). 
 
 Having obtained PDCD5 as an interaction partner of CCT5, it would be 
reasonable to assume that perhaps the TCP-1 ring complex could be playing a 
role in either the folding of the PDCD5 protein as a whole, or simply folding its 
N-terminal region into the stable α-helical structure. Once folded properly, the 
TCP-1 ring complex could be the molecular chaperone responsible for the 
translocation across the nucleus when needed. If that was to be true, we would 
have expected to observe an interaction between PDCD5 and the purified 
CCT4, which is unfortunately not the case. This does not mean that the 
interaction does not occur; the interaction could simply not be abundant.  
TAP purification of PDCD5 is currently being done in our laboratory to 
hopefully, confirm its interaction with CCT5, and to determine if other TCP-1 
ring complex subunits might be identified with it.  
 
5-3) PFDN2, PDRG1, PIH1D1, WDR92 and the URI/Prefoldin complex: 
 Our results show that, using the TAP approach to purify PFDN2, 
PDRG1, PIH1D1 and WDR92, we were able to purify the URI/Prefoldin 
complex. As we mentioned earlier, the URI/Prefoldin complex has not been 
assigned any specific function until now, but from what is known about its 
components and by purifying most of them, either in this project or by work 
done in our laboratory (for RPAP3, RUVBL1, RUVBL2, UXT, RPB5 and 
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PFDN6), and identifying their interaction partners, hypotheses could be made 
about the role this complex might be playing in mammalian cells. 
  
5-3.1) First Hypothesis: URI/Prefoldin complex might be involved in 
the proper folding of Rpb5 or in the assembly  of RNA polymerases: 
 Several components of the URI/Prefoldin complex are subunits of the 
prefoldin complex such as PFDN2 and PFDN6, and prefoldin- like proteins 
such as UXT, URI and PDRG1 (a PFDN4-like protein).  
It is worth pointing out that, aside from PFDN2 and PFDN6, PDRG1 is 
the only component of the URI/Prefoldin complex which picked up all of the 
prefoldin subunits except PFDN4, when purified. The questions raised now are; 
does the prefoldin complex exist in two different states, one with PFDN4 and 
another with PDRG1 instead? If so, how do these two complexes differ in 
activity? Furthermore, is the PDRG1-Prefoldin complex unique to the 
URI/Prefoldin complex?    
 Knowing that the URI/Prefoldin complex consists of several prefoldins 
and prefoldin-like proteins, and that Rpb5 is a component of the complex, the 
first assumption that could be made is that, perhaps, this complex might be 
playing a role in the proper folding of Rpb5.  
 RPAP3 is another member of the complex which has previously been 
shown to interact with several subunits of RNAPI, RNAPII and RNAPIII 
(Jeronimo et al., 2007). Since Rpb5 is a common subunit to all three 
polymerases, it is plausible to speculate that the URI/Prefoldin complex might 
be playing a role in the assembly of RNA polymerases. 
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 5-3.2) Second Hypothesis: The URI/Prefoldin complex might be 
involved in the regulation of transcription by the RNAPII:  
 URI (Unconventional Prefoldin Rpb5 Interactor) is a prefoldin-like 
protein, also referred to as RMP for Rpb5-mediating protein, that has been 
reported to negatively modulates transcription through its interaction with the 
RNAPII subunit 5 “Rpb5”, a common subunit of all three RNA polymerases 
(Wei et al., 2003, Dorjsuren et al., 1998). URI’s negative modulation of 
transcription was first observed by its ability to interact with Rpb5, through its 
Rpb5-binding domain, and counteract transactivation by HBx, the 
multifunctional viral regulator protein of hepatitis B virus, which was 
previously shown to directly interact with Rpb5 and TFIIB and facilitate 
transcription (Wei et al., 2003, Dorjsuren et al., 1998). URI has also been 
shown to regulate transcription through interaction with TFIIF, a general 
transcription factor that functions in both transcription initiation and elongation. 
This could be another pathway in which URI is able to regulate transcription. It 
is also possible that TFIIF may cooperate with Rpb5 and TFIIB for the 
corepressor function of URI (Wei et al., 2003).  
 Functional analysis of URI in yeast has revealed that it is a downstream 
substrate of TOR which acts to control nutrient- sensitive gene expression. In 
mammalian cells, URI was found to be in a phosphorylated state, influenced by 
signals that affect the activity of mTOR, and positively contributes to 
rapamycin- sensitive transcription (Gstaiger et al., 2003, Djouder et al., 2007).  
 Thus, in both cases, involving either interaction with RPB5 or the 
rapamycin- sensitive signaling pathway of mTOR, URI is involved in 
modulating transcription by RNAPII. Therefore, it can be postulated that the 
URI/Prefoldin complex might be involved in the regulation of transcription by 
RNAPII. 
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 5-3.3) Third Hypothesis: The URI/Prefoldin complex might be 
involved in RNA processing: 
 PIH1D1 is another component of the URI/Prefoldin complex. Recently, 
Pih1, the yeast homologue of the human PIH1D1, was identified as a member 
of a newly discovered complex, the R2TP complex, together with Tah1, Rvb1 
and Rvb2 (the yeast homologues of the human RUVBL1 and RUVBL2) (Zhao 
et al., 2008). 
 Pih1 was shown to be an unstable protein of the R2TP complex under 
normal conditions (log phase of yeast), but is not prone for degradation. 
Therefore, it was assumed that chaperones, which have not yet been identified, 
might be involved in its stabilization under normal conditions. On the other 
hand, under stress condition (stationary phase of yeast), it was demonstrated 
that Hsp90 together with Tah1 stabilize Pih1 (Zhao et al., 2008). The R2TP 
complex, in fact, was found to interact with the Hsp90 chaperone, and this 
interaction is required for the correct accumulation of box C/D snoRNPs, which 
consist of box C/D snoRNAs associated with a set of core proteins, especially 
under stress conditions (Zhao et al., 2008). snoRNPs, themselves, are trans- 
acting regulators responsible for cleavage and modifications of snRNAs, rRNAs 
and tRNAs (Matera et al., 2007, Zhao et al., 2008). 
 The URI/Prefoldin complex does contain the human homologs of Pih1, 
Rvb1 and Rvb2, which are PIH1D1, RUVBL1 and RUVBL2 respectively. 
Tah1, on the other hand, is a protein that contains two tetratricopeptide repeats 
(TPRs), and until now, its human orthologue has not been identified yet; 
however it is believed that other TPR domain-containing proteins might serve 
as an alternative for Tah1 in human cells (Zhao et al., 2008). One component of 
the URI/Prefoldin complex is a TPR domain-containing protein, RPAP3, which, 
in fact, contains two TPR domains. Previous TAP purification of RPAP3 did 
yield Hsp90 as an interaction partner of the purified RPAP3 complex (results 
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reported in Jeronimo et al., 2007). Therefore, it is reasonable to assume that 
RPAP3 could be the human orthologue of the yeast Tah1, and thus, the 
URI/Prefoldin complex might be playing an important role in RNA processing. 
 5-3.4) Fourth Hypothesis: The URI/Prefoldin complex might play an 
important role in apoptosis: 
 mTOR is a protein that coordinately controls cell growth in response to 
growth factors and the availability of nutrients. One of its downstream effector 
proteins is S6K1, which promotes protein synthesis and cell survival (Sabatini 
2006, Wullschleger et al., 2006, and Djouder et al., 2007). In response to 
growth factors, S6K1 was found to phosphorylate URI (at Ser-371) found 
associated with PP1γ at the mitochondria. This phosphorylation leads to the 
dissociation of URI/PP1γ. PP1γ now released contributes to the downregulation 
of S6K1 activity in vivo, thus, enhancing a cell’s susceptibility to undergo 
apoptosis (Djouder et al., 2007).  
 Furthermore, WDR92, a component of the URI/Prefoldin complex,  has 
been suggested to play a role as a novel modulator of apoptosis pathway 
induced by TNF-α, as discussed earlier in section 1 (Saeki et al., 2006). In 2007, 
it was reported that the knockdown of UXT, which is a prefoldin-like 
component of the URI/Prefoldin complex, sensitizes cells to apoptosis induced 
by TNF-α (Sun et al., 2007). It is therefore reasonable to assume that the 
URI/Prefoldin complex might be playing an important role in apoptosis. 
 As can be observed, the output of the AP-MS procedure not only helps 
in forming an idea or inferring a function to the proteins of previously unknown 
function, but also in identifying new interaction partners that are either 
unexpected or that have not been previously characterized. It is, however, these 
proteins that are unexpected that are often the most promising in terms of 
proteomic discovery (Cloutier et al., 2007). Furthermore and as discussed 
earlier, the output of the AP-MS procedure did help us in forming an idea or 
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coming up with hypotheses about the role some of these proteins might be 
playing in mammalian cells. This information is crucial and will help, later on, 
directing us in choosing the kind of functional assays needed to study the 
function of these proteins and to confirm or reject the presented hypotheses 
some of which are currently being studied in our laboratory.  
 
 It is evident that large-scale, genome-wide protein-protein interaction 
screens and the mapping of protein interaction networks are now showing a 
great potential in the identification of novel therapeutic targets and putative 
biomarkers to be used as diagnostic tools, and are key in understanding the 
molecular mechanisms of diseases (Oltersdorf et al., 2005, Al-Khoury R. and 
Coulombe B. 2009). The resulting protein interaction maps represent in many 
ways the fingerprint of the physiological status of a cell and their modulation is 
predicted to represent the signature of specific disease conditions, including 
those observed in cancers, viral infections and other pathological conditions 
(Coulombe et al., 2008, Al-Khoury R. and Coulombe B. 2009). 
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Section 6: Conclusion and Perspectives 
 
 In efforts of defining the interaction network of soluble protein 
complexes in human cells, our laboratory was interested in defining the 
interaction network involving the human RNAPII machinery using the TAP 
purification method. This approach has proven to be very powerful allowing for 
a large-scale study of protein interaction networks. 
 The aim of my project was to further pursue our survey of soluble 
protein complexes containing components of the human transcription 
machinery, using the same TAP method. Eight newly identified RNAPII 
interaction partners were chosen for TAP purification (KIAA0406, WDR92, 
PIH1D1, PFDN2, GPN3, CCT4, CCT5 and PDRG1) to determine their own 
interaction partners and perhaps identify some novel interacting proteins. A 
novel interacting partner was only identified with CCT5, and it is PDCD5, 
which is a very interesting protein, and currently, work for its TAP purification 
is being pursued in the laboratory.  
 Several of the chosen proteins were of an unknown function and we 
hoped that by identifying their interaction partners it would be possible to infer 
putative functions to them. For all of these proteins, we were able to come up 
with assumptions and hypotheses about their function from their interaction 
partners, but biochemical and functional approaches still need to be applied to 
either validate or reject these hypotheses. 
 Using the TAP purification method, we were also able to purify the 
URI/Prefoldin complex which includes, in addition to other proteins, several of 
the proteins that were purified in my project. Using what is known in the 
literature about some of its components and having identified the interaction 
partners of most of its components, we were able to come up with few 
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interesting hypothesis, mentioned earlier in section 5, about the kind of a role 
this complex might have in human cells. These hypotheses will be further 
investigated in the laboratory in efforts of deciphering the function of the 
URI/Prefoldin complex. 
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